<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: dan</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'dan'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22dan%22&t=%22dan%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 01:55:38 +0100</lastBuildDate>
        <item>
            <title>The Situation of the Inequality Getting Inequalitier</title>
            <link>http://www.medworm.com/index.php?rid=5181919&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2011%2F09%2F01%2Fthe-situation-of-the-inequality-getting-inequalitier%2F</link>
            <description>From PBSNewsHour:
Financial gains over the last decade in the United States have been mostly made at the &amp;#8220;tippy-top&amp;#8221; of the economic food chain as more people fall out of the middle class. The top 20 percent of Americans now holds 84 percent of U.S. wealth, as Paul Solman found out as part of a Making Sen$e series on economic inequality. (Source: The Situationist)</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5181919</comments>
            <pubDate>Thu, 01 Sep 2011 18:34:21 +0100</pubDate>
            <guid isPermaLink="false">5181919</guid>        </item>
        <item>
            <title>Dan Hannan MEP</title>
            <link>http://www.medworm.com/index.php?rid=5181910&amp;cid=t_117220_109_f&amp;fid=34786&amp;url=http%3A%2F%2Fdrmichelletempest.blogspot.com%2F2011%2F08%2Fdan-hannan-mep.html</link>
            <description>(Source: The Psychiatrist Blog)</description>
            <author>The Psychiatrist Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5181910</comments>
            <pubDate>Wed, 31 Aug 2011 16:02:00 +0100</pubDate>
            <guid isPermaLink="false">5181910</guid>        </item>
        <item>
            <title>Is Non-Monogamy The Key To An Affair-Free Marriage?</title>
            <link>http://www.medworm.com/index.php?rid=5036276&amp;cid=t_117220_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2011%2F07%2F16%2Fis-non-monogamy-the-key-to-an-affair-free-marriage%2F</link>
            <description>With each new sex scandal splashed across headlines, it&amp;#8217;s become impossible to hide from the realities of marriage, i.e., monogamy is hard. And with so many high-profile persons seemingly shirking fidelity, it&amp;#8217;s easier for couples unsatisfied in their relationship to start wondering if these cheating politicians just may have the right idea. It&amp;#8217;s these concerns and questions that The New York Times Magazine took on when reaching out to leading sex-advice columnist, Dan Savage for their recent exploration of monogamy and marriage.
Savage tells the Times that many of us have a hard time admitting that being monogamous is difficult. He believes that when people treat monogamy as the sole indicator of a successul marriage, it casts unrealistic expectations for not only themse...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5036276</comments>
            <pubDate>Sat, 16 Jul 2011 18:45:28 +0100</pubDate>
            <guid isPermaLink="false">5036276</guid>        </item>
        <item>
            <title>Apologies Really DO Work</title>
            <link>http://www.medworm.com/index.php?rid=5028469&amp;cid=t_117220_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F26415427%2F0%2Fneuromarketing%7EApologies-Really-DO-Work.htm</link>
            <description>Have you ever annoyed a potential customer, or made her angry? Before you decide to ignore the faux pas and press forward with the pitch, or write her off and move on to greener pastures, try this simple technique: say, &amp;#8220;I&amp;#8217;m sorry.&amp;#8221; That&amp;#8217;s likely instinctive behavior for many of us, but at times it may [...]
      CommentsAgree, Wes. If I'm rude once and immediately acknowledge it ... by Roger Dooleyon Page's topic,  There was similar discussion in this topic ... by Wes ManPlus 7 more...Related StoriesThe Upside of Irrationality by Dan ArielyNeuromarketing Explains Weiner&amp;#8217;s PickleYour Brain&amp;#8217;s Twitter Limit: 150 Real Friends (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5028469</comments>
            <pubDate>Thu, 14 Jul 2011 17:54:35 +0100</pubDate>
            <guid isPermaLink="false">5028469</guid>        </item>
        <item>
            <title>The Upside of Irrationality by Dan Ariely</title>
            <link>http://www.medworm.com/index.php?rid=5028470&amp;cid=t_117220_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F26392869%2F0%2Fneuromarketing%7EThe-Upside-of-Irrationality-by-Dan-Ariely.htm</link>
            <description>Nobody is doing more to add to our knowledge of the irrational side of human behavior than Dan Ariely. Not only does he conduct experiments that are elegant in their simplicity, but he writes about his work and that of other researchers in a highly acccessible way. Upside is the successor to the bestselling Predictably Irrational, and it takes to new topics, ranging from CEO pay to speed dating.
      Comments[...] The Upside of Irrationality, Dan Ariely describes an ... by Apologies Really DO Work &amp;#124; Neuromarketing[...] Dooley (Neuroscience Marketing) writes about Dan Ariely ... by Can a Crappy Video Effect Your Decision Making? &amp;#124; Will Video for FoodThanks, nice review.  I loved Predictably Irrational. I think ... by Luke FosterRelated StoriesApologies Really DO WorkSecrets of th...</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5028470</comments>
            <pubDate>Tue, 12 Jul 2011 13:52:51 +0100</pubDate>
            <guid isPermaLink="false">5028470</guid>        </item>
        <item>
            <title>Does Asia Need a Larger U.S. Handout?</title>
            <link>http://www.medworm.com/index.php?rid=5008146&amp;cid=t_117220_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FD05UyuVj7sQ%2F</link>
            <description>By Justin LoganYesterday, AEI scholars Dan Blumenthal and Michael Mazza authored an interesting op-ed in the Wall Street Journal with a perplexing title: &amp;#8220;Asia Needs a Larger U.S. Defense Budget.&amp;#8221; There are a couple of more sensible arguments you could make: For instance, that Asian countries need larger defense budgets, or that U.S. interests in Asia require larger military expenditures that Asian countries can&amp;#8217;t or won&amp;#8217;t make themselves . Blumenthal and Mazza gesture at both of those arguments but don&amp;#8217;t really make either one. As such, the piece is an emblem of what&amp;#8217;s wrong with the Asia policy discussion&amp;#8211;to the extent it exists&amp;#8211;in Washington today.
In the opening paragraph, the authors state that &amp;#8220;it is&amp;#8230;difficult to assess how ...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5008146</comments>
            <pubDate>Wed, 06 Jul 2011 20:07:16 +0100</pubDate>
            <guid isPermaLink="false">5008146</guid>        </item>
        <item>
            <title>I Did It! Tour de Cure!</title>
            <link>http://www.medworm.com/index.php?rid=4934707&amp;cid=t_117220_134_f&amp;fid=35179&amp;url=http%3A%2F%2Fscottsdiabetes.com%2F2011%2F06%2Ftour-de-cure%2F</link>
            <description>Scott, Mari, Heather
Have you ever gotten yourself into something you weren&amp;#8217;t quite sure you could do?  I got myself very familiar with that feeling this Spring.
When we finished the 25-mile Tour de Cure route last year I wasn&amp;#8217;t ready to be finished.  I wanted more.  So for the 2011 ride we signed up for the 45-mile course.
The weather here this &amp;#8220;Spring&amp;#8221; (note the quotation marks&amp;#8230;) was terrible.  Cold, wet, rainy, overcast.  If you had to paint a picture of depression, any weekend of Minnesota leading up to the ride would have been perfect.
Last year, for the 25-mile ride, I went on a lot of training rides with the team before the big day.  This year?  I was on my bike twice.  Completing a 14-mile ride the first time, and a 20-mile ride the second.  T...</description>
            <author>Scott's Diabetes Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4934707</comments>
            <pubDate>Mon, 13 Jun 2011 11:57:09 +0100</pubDate>
            <guid isPermaLink="false">4934707</guid>        </item>
        <item>
            <title>Neuromarketing Explains Weiner’s Pickle</title>
            <link>http://www.medworm.com/index.php?rid=4921524&amp;cid=t_117220_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F26112553%2F0%2Fneuromarketing%7ENeuromarketing-Explains-Weiners-Pickle.htm</link>
            <description>The latest news on the lewd messaging scandal involving Congressman Anthony Weiner (Democrat, NY) was that he called former President Bill Clinton (who officiated at Weiner&amp;#8217;s wedding) to apologize for his behavior. No transcript of the conversation was released, but it must have been an interesting chat. Did the ex-pres say something like, &amp;#8220;Dude, I [...]
      CommentsHa! Well, you found your excuse.  Jennifer (Verilliance) ... by Jennifer (Verilliance)Actually, I was just looking for an excuse to use ... by Roger DooleyPlus 2 more...Related StoriesCloser to the Buy Button?Your Brain&amp;#8217;s Twitter Limit: 150 Real FriendsVivid Print Ads Change Your Memory (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4921524</comments>
            <pubDate>Thu, 09 Jun 2011 13:01:07 +0100</pubDate>
            <guid isPermaLink="false">4921524</guid>        </item>
        <item>
            <title>The Dan Markingson files now online : Investigative reporting continues on the Seroquel trial gone bad at the University of Minnesota</title>
            <link>http://www.medworm.com/index.php?rid=4841930&amp;cid=t_117220_140_f&amp;fid=35439&amp;url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2011%2F05%2Fdan-markingson-files-now-online.html</link>
            <description>(Source: soulful sepulcher)</description>
            <author>soulful sepulcher</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4841930</comments>
            <pubDate>Wed, 18 May 2011 14:44:00 +0100</pubDate>
            <guid isPermaLink="false">4841930</guid>        </item>
        <item>
            <title>On Money and Motivation</title>
            <link>http://www.medworm.com/index.php?rid=4768050&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2011%2F04%2F30%2Fon-money-and-motivation%2F</link>
            <description>This lively RSAnimate, adapted from Dan Pink&amp;#8217;s talk at the RSA, examines some the ways that money doesn&amp;#8217;t always buy motivation.
Related Situationist posts:

Shocking for Money
The Situation of High Marginal Income Tax Rates and Motivation
Money and the Situation of Happiness
“The Situation of Money and Happiness,”
“Receiving by Giving,” and 
“Something to Smile About.” 

To review a collection of Situationist posts exploring the causes and consequences of happiness, click here. (Source: The Situationist)</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4768050</comments>
            <pubDate>Sat, 30 Apr 2011 04:01:58 +0100</pubDate>
            <guid isPermaLink="false">4768050</guid>        </item>
        <item>
            <title>A Seroquel Clinical Trial And Academic Freedom</title>
            <link>http://www.medworm.com/index.php?rid=4759039&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FlVjvoT8rNwo%2F</link>
            <description>The sad case of Dan Markingson appears to have no end. The latest twist is playing out as an issue of academic freedom at the University of Minnesota where, seven years ago, researchers ran a clinical trial in which the 26-year-old participated. But the circumstances surrounding his participation and subsequent death led to widely publicized allegations the university put its own interests first.
One university researcher also consulted for AstraZeneca, which sells the drug and sponsored the study. And researchers were allegedly under pressure to bolster enrollment. These details emerged following a lawsuit filed by Markingson’s mother, who objected to her son’s participation because he was already mentally ill and possibly incompetent, but was enrolled anyway. 
Her lawsuit went nowher...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4759039</comments>
            <pubDate>Wed, 27 Apr 2011 15:16:18 +0100</pubDate>
            <guid isPermaLink="false">4759039</guid>        </item>
        <item>
            <title>The 50 Greatest Motivational Quotes Of All Time – And Why!</title>
            <link>http://www.medworm.com/index.php?rid=4747925&amp;cid=t_117220_180_f&amp;fid=38619&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FALifeCoachsBlog%2F%7E3%2FSoJ56Y-b3J0%2F</link>
            <description>When I was a kid and my dad would tell me to do something I didn’t particularly want to do like tidy my bedroom, I’d usually whine:
“But why do I have to do it now when I’m busy pushing superglue into my sisters toothpaste tube?”
My dad being the brilliant philosopher and debater that he was, would almost always respond by saying:
“Because I said so”
“Oh well” I’d think, “Why didn’t he say that in the first place?” and with that I’d happily put down the glue and start to clear the room up.
It sounds completely ridiculous, doesn’t it?
Responding, “because I said so” isn&amp;#8217;t really a compelling argument. After all, I knew he’d said so there was no need to tell me that, other than it worked more often that not.
Fast forward a few decades and I’m readi...</description>
            <author>Life Coach Blog: The Discomfort Zone :</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4747925</comments>
            <pubDate>Sun, 24 Apr 2011 18:44:25 +0100</pubDate>
            <guid isPermaLink="false">4747925</guid>        </item>
        <item>
            <title>The Psychological Situation of Climate Change</title>
            <link>http://www.medworm.com/index.php?rid=4723958&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2011%2F04%2F17%2Fthe-psychological-situation-of-climate-change%2F</link>
            <description>Situationist friend, Daniel Gilbert, Professor of Psychology, describes the psychological impulses that make it difficult for humans to confront the threat of global warming.

Related Situationist posts:

Dan Gilbert on Why the Brain Scares Itself
“Dan Gilbert To Speak at Harvard Law School,” 
“Dan Gilbert on the Situation of Our Decisions,” 
“Dan Gilbert on the Situation of Psychology,” 
“The Situation of Climate Change,” 
“The Heat is On,” 
“The Situation of Happiness,” and 
“Conversation with Dan Gilbert.” (Source: The Situationist)</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4723958</comments>
            <pubDate>Sun, 17 Apr 2011 16:54:35 +0100</pubDate>
            <guid isPermaLink="false">4723958</guid>        </item>
        <item>
            <title>Facial EMG: Muscles Don’t Lie?</title>
            <link>http://www.medworm.com/index.php?rid=4676873&amp;cid=t_117220_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F25442074%2F0%2Fneuromarketing%7EFacial-EMG-Muscles-Dont-Lie.htm</link>
            <description>We talk a lot about EEG measurements for neuromarketing purposes, and occasionally fMRI. We&amp;#8217;ve also discussed facial coding, in which expert viewers analyze fleeting facial expressions to detect emotional states. A technique related to facial coding but with some distinct differences is facial EMG. This technology uses electromyography to measure the activity of two primary [...]
      CommentsIn my view, facial EMG is useful only if we can link it with ... by PavaRelated StoriesStirring the Neuromarketing PotARF on Neuromarketing: Not So FastEasier Neuromarketing Studies with Mynd (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4676873</comments>
            <pubDate>Mon, 04 Apr 2011 12:23:26 +0100</pubDate>
            <guid isPermaLink="false">4676873</guid>        </item>
        <item>
            <title>Stirring the Neuromarketing Pot</title>
            <link>http://www.medworm.com/index.php?rid=4653381&amp;cid=t_117220_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F25358118%2F0%2Fneuromarketing%7EStirring-the-Neuromarketing-Pot.htm</link>
            <description>The gloves are coming off in the debate about which neuromarketing technologies are most effective. The initial &amp;#8220;neurostandards&amp;#8221; report from the Advertising Research Foundation didn&amp;#8217;t pick any winners from the different approaches to measuring consumer response; the draft report was as carefully worded as a negotiated United Nations resolution. But Dan Hill, president of Sensory [...]
      CommentsDefinitely agree, and my guess is that neuromarketing firms can ... by JenniferJennifer, I agree, ROI is the best metric of all. I'm not hung ... by Roger DooleyI find this debate about tests needing to bear peer scrutiny to ... by JenniferRelated StoriesEasier Neuromarketing Studies with MyndARF on Neuromarketing: Not So FastUse Ratings to Improve REAL Satisfaction (Source: Ne...</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4653381</comments>
            <pubDate>Tue, 29 Mar 2011 16:04:36 +0100</pubDate>
            <guid isPermaLink="false">4653381</guid>        </item>
        <item>
            <title>What To Do About Pharma CEO Compensation</title>
            <link>http://www.medworm.com/index.php?rid=4622504&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FGD7EsfMNbB4%2F</link>
            <description>In this age of skyrocketing compensation for chief executives and dwindling prospects for drugmakers, there is increasing investor angst that boardrooms are either out of touch, unimaginative or simply indifferent to the protestations that pay packages do not match shareholder interests. The issue has engulfed Johnson &amp;#038; Johnson&amp;#8217;s Bill Weldon and, in years past, Dan Vasella at Novartis, for instance.
So what to do? Well, pharma boards could start by shifting away from an emphasis on financial measurements - such as EPS, or earnings per share, and EBITDA, or earnings before interest, taxes, depreciation and amortization - to calculate and compare performance, and start focusing on pipeline innovation, according to The Hay Group, a consulting firm that measured ceo pay and incentiv...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4622504</comments>
            <pubDate>Tue, 22 Mar 2011 13:40:01 +0100</pubDate>
            <guid isPermaLink="false">4622504</guid>        </item>
        <item>
            <title>See the Future of Apple and more with Dan Burrus</title>
            <link>http://www.medworm.com/index.php?rid=4570778&amp;cid=t_117220_180_f&amp;fid=38604&amp;url=http%3A%2F%2Fwww.philgerbyshak.com%2Fpg-com%2Fwp-content%2Fuploads%2F2011%2F03%2Fflash_foresight_dan_burrus_18m.mp3</link>
            <description>Today I am honored to bring you the amazing Dan Burrus, author of Flash Foresight, See the Invisible and Do the Impossible, on the Post 2 Post tour.

Dan started his tour over at Principled Innovation with Jeff De Cagna (@pinnovation) on Monday, then moved on to The Fresh Peel with Chris Wilson (@FreshPeel) on Tuesday, then to BrandMix with Martin Bishop (@martinjbishop) on Wednesday, today he’s visiting me, and tomorrow, he’ll be wrapping up his tour over at my buddy Rajesh Setty’s Blog where he’s busy Bringing Ideas To Life (@RajSetty).
What would you do if you could predict the future?
Don&amp;#8217;t believe you can predict the future?
Stay tuned and listen to me interview Dan Burrus, author of the great new book Flash Foresight.
In the book, Dan focuses on 2 types of change that w...</description>
            <author>Phil Gerbyshak</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4570778</comments>
            <pubDate>Thu, 10 Mar 2011 12:00:00 +0100</pubDate>
            <guid isPermaLink="false">4570778</guid>        </item>
        <item>
            <title>Novartis Chairman Vasella Gets Criticized Over Pay</title>
            <link>http://www.medworm.com/index.php?rid=4512616&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FH-3P5Te9uPI%2F</link>
            <description>Once again, the pay package given Novartis chairman Dan Vasella is causing a ruckus. At the annual meeting yesterday in Basel, Switzerland, only 61 percent of shareholders backed the compensation plan, the first time remuneration was put to a vote. This is not considered a very good showing, however, and in fact, Dan and Novartis ceo Joe Jimenez were criticized for their salaries and because a chunk of their pay is not tied to long-term performance, The Wall Street Journal writes. 
So what did Dan receive? According to the Novartis annual report, he earned about $8.5 million last year, including cash and stock. Separately, Dan also received a one-time retirement benefit worth $12.8 million. But Ethos, a shareholder activist organization, calculates he earned around $27 million. And Rudolf ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4512616</comments>
            <pubDate>Wed, 23 Feb 2011 13:20:40 +0100</pubDate>
            <guid isPermaLink="false">4512616</guid>        </item>
        <item>
            <title>University Exonerates Itself Over Seroquel Trial</title>
            <link>http://www.medworm.com/index.php?rid=4450518&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FSxHKLul2w-s%2F</link>
            <description>Nearly seven years ago, 26-year-old Dan Markingson killed himself while participating in a clinical trial at the University of Minnesota, where researchers were studying the Seroquel antipsychotic. And the circumstances surrounding his participation and subsequent death led to widely publicized allegations that the university put its own interests ahead of the patient.
How so? One reason - an academic researcher also consulted for AstraZeneca, which markets the pill and sponsored the study. And the researchers were allegedly under pressure to bolster enrollment. These details emerged following a lawsuit filed by Markingson&amp;#8217;s mother, who objected to her son&amp;#8217;s participation because he was already mentally ill and possibly incompetent, but was enrolled anyway (background here). 
H...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4450518</comments>
            <pubDate>Tue, 08 Feb 2011 21:21:42 +0100</pubDate>
            <guid isPermaLink="false">4450518</guid>        </item>
        <item>
            <title>“It Gets Better” tops 2010 list</title>
            <link>http://www.medworm.com/index.php?rid=4298764&amp;cid=t_117220_135_f&amp;fid=35247&amp;url=http%3A%2F%2Fmyjourneywithaids.wordpress.com%2F2010%2F12%2F29%2Fit-gets-better-tops-2010-list%2F</link>
            <description>Dan Savage and husband Terry Miller started something in 2010 that Mark Kelley and the CBC Connect crew put at the top of Connect 10: A  Countdown of the most popular stories online in 2010. Responding to highly-publicized cases of bullying and suicides of gays and lesbians, the “It Gets Better” project was launched with [...] (Source: My journey with AIDS)</description>
            <author>My journey with AIDS</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4298764</comments>
            <pubDate>Thu, 30 Dec 2010 03:09:31 +0100</pubDate>
            <guid isPermaLink="false">4298764</guid>        </item>
        <item>
            <title>Did You See the Gorilla? An Interview with Psychologist Daniel Simons</title>
            <link>http://www.medworm.com/index.php?rid=4200632&amp;cid=t_117220_122_f&amp;fid=36582&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FSharpBrains%2F%7E3%2F5mmtPdWD4bg%2F</link>
            <description>If you’ve spent any time on YouTube over the last few years (and you know you have), you’ve likely seen the video of the invisible gorilla experiment (if you’ve somehow missed it, catch yourself up here). The researchers who conducted that study, Dan Simons and Chris Chabris, didn’t realize that they were about to create an instant classic—a psychology study mentioned alongside the greats, and known well outside the slim confines of psych wonks. Milgram taught us about our sheepish obedience to authority; Mischel used marshmallows to teach us about delayed gratification; and Simons and Chabris used a faux gorilla to teach us that we are not the masters of attention we think we are.
The duo’s new book, The Invisible Gorilla, and Other Ways Our Intuitions Deceive Us, is every...</description>
            <author>SharpBrains</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4200632</comments>
            <pubDate>Wed, 24 Nov 2010 21:13:26 +0100</pubDate>
            <guid isPermaLink="false">4200632</guid>        </item>
        <item>
            <title>Avoid the Corner of Death!</title>
            <link>http://www.medworm.com/index.php?rid=4119088&amp;cid=t_117220_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F21690540%2F0%2Fneuromarketing%7EAvoid-the-Corner-of-Death.htm</link>
            <description>What&amp;#8217;s the worst place to put your logo, and where do advertisers most often put their logo in print ads, TV spots, and direct mail pieces? The answer is the same: the lower right corner, an area dubbed the &amp;#8220;Corner of Death&amp;#8221; by facial coding expert Dan Hill. Hill&amp;#8217;s comments stem from an interesting eyetracking [...]
      Comments[...] the Corner of Death!  The worst placement for your [...] by Dawn&amp;#8217;s Weekly World News 10 29 2010[...] called “Avoid the Corner of Death!,” and it is ... by Understanding Eye Flow and Avoiding The Corner of Death &amp;#171; MARKETING STRATEGISTPlus 4 more...Related StoriesMore Senses, Higher SalesHire Happy People!New Gap Logo a Neuro Failure (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4119088</comments>
            <pubDate>Thu, 28 Oct 2010 12:31:01 +0100</pubDate>
            <guid isPermaLink="false">4119088</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=4106064&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FjEVliExIRuE%2F</link>
            <description>Hello, everyone. Nice to see you again. Hope your weekend was refreshing and relaxing. Now, of course, the routine returns as we gear up for those meetings and deadlines. To cope, we are brewing our favorite cup of stimulation. Please join us as we peruse the news of the world and continue our quest for interesting items. Tidbits are always welcome. Hope your day goes well and see you soon&amp;#8230;
Novartis Menveo Vaccine Protects Infants In Study (Bloomberg News)
Glaxo Cuts Cervarix Price By 30 Percent In Canada (Reuters)
Chinese SFDA Steps Up Fake Avastin Investigation (Shanghai Daily)
Alcon Names Dan Vasella As Chairman (MarketWatch)
FDA Finds High Levels Of Peroxide In Batch of Crospovidone (InPharma-Technologist)
J&amp;#038;J Faces UK Class-Action Suit Over Hip Devices (The Daily Mail)
Penn...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4106064</comments>
            <pubDate>Mon, 25 Oct 2010 11:40:04 +0100</pubDate>
            <guid isPermaLink="false">4106064</guid>        </item>
        <item>
            <title>Hire Happy People!</title>
            <link>http://www.medworm.com/index.php?rid=4105768&amp;cid=t_117220_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F21563806%2F0%2Fneuromarketing%7EHire-Happy-People.htm</link>
            <description>Want your customers to have a better experience? Instead of trying to train your employees to smile, just hire happy people. Apparently, you don&amp;#8217;t have to be an expert in reading faces to tell the difference between a real smile and a &amp;#8220;social smile.&amp;#8221; The latter is what facial coding experts call the smile we [...]
      CommentsAnyone who deals with customers must be a happy person in our ... by Pablo EdwardsThat's interesting, Denise – I guess a “social smile” ... by Roger DooleyPlus 8 more...Related StoriesMore Senses, Higher SalesBit Pickles &amp; Fuzzy OlivesNeuro-Politics: Chinese Professor Ad (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4105768</comments>
            <pubDate>Fri, 22 Oct 2010 12:57:42 +0100</pubDate>
            <guid isPermaLink="false">4105768</guid>        </item>
        <item>
            <title>More Senses, Higher Sales</title>
            <link>http://www.medworm.com/index.php?rid=4105769&amp;cid=t_117220_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F21541806%2F0%2Fneuromarketing%7EMore-Senses-Higher-Sales.htm</link>
            <description>What two senses get all the attention in advertising? Sight and sound. Print, broadcast, and digital media usually reach only these two, and often just one. In his new book, About Face, Dan Hill spends some time focusing on how reaching the other senses with your marketing can boost sales. Here are a few sensory [...]
      CommentsHello,  it is also important to note that when we try to sell ... by Sergio - videos de bodasThe number is incorrect – and I guess the question is who are ... by TracyPlus 8 more...Related StoriesHire Happy People!Neuro-Politics: Chinese Professor AdAbout Face by Dan Hill (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4105769</comments>
            <pubDate>Thu, 21 Oct 2010 12:52:57 +0100</pubDate>
            <guid isPermaLink="false">4105769</guid>        </item>
        <item>
            <title>Best of Our Blogs: October 1, 2010</title>
            <link>http://www.medworm.com/index.php?rid=4022956&amp;cid=t_117220_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2010%2F10%2F01%2Fbest-of-our-blogs-october-1-2010%2F</link>
            <description>Can it be? Is it really the end of September? According to our Twitter followers, I might not be the only one feeling the swiftness of September.
It&amp;#8217;s funny how no matter how hard we try to pay attention to every moment, the days and moments still fly by. And here we are again, another month is gone. Soon it will be winter and then 2011!
The good news is that the rapidity of time makes it all the more valuable and a worthy cause to find the goodness in all situations. Like how Mindfulness &amp; Psychotherapy is showing us how to do it this week and kind of like how Mentoring &amp; Recovery is teaching us how to be more of a inner coach rather than an inner critic.
It&amp;#8217;s all of these things that show us how to live life more meaningfully that helps the moments go by just a little...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4022956</comments>
            <pubDate>Fri, 01 Oct 2010 13:32:28 +0100</pubDate>
            <guid isPermaLink="false">4022956</guid>        </item>
        <item>
            <title>Army Captain and Double Amputee Dan Luckett Returns To Front Line Combat Two Years After Injury In Iraq</title>
            <link>http://www.medworm.com/index.php?rid=4001674&amp;cid=t_117220_83_f&amp;fid=34856&amp;url=http%3A%2F%2Finsidesurgery.com%2F2010%2F09%2Farmy-captain-double-amputee-dan-luckett-returns-front-line-combat-years-injury-iraq%2F</link>
            <description>Army Captain Dan Luckett of the 101st Airborne Division lost parts of both of his legs while on patrol in Iraq. After several surgeries by Army surgeons and a grueling rehab at Walter Reed Medical Center, Capt Luckett passed every physical fitness test and is back on the frontlines &amp;#8211; leading combat patrols in Afghanistan. Hooah!! (Source: Inside Surgery)</description>
            <author>Inside Surgery</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4001674</comments>
            <pubDate>Sat, 25 Sep 2010 19:54:18 +0100</pubDate>
            <guid isPermaLink="false">4001674</guid>        </item>
        <item>
            <title>Wear a Fake Rolex, Turn Into O.J.</title>
            <link>http://www.medworm.com/index.php?rid=3965501&amp;cid=t_117220_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F20639460%2F0%2Fneuromarketing%7EWear-a-Fake-Rolex-Turn-Into-OJ.htm</link>
            <description>You can find fake designer and luxury products just about anywhere these days, and most people consider owning one a harmless transgression. After all, if you were never going to pay $12,000 for a real Rolex, who is really hurt if you wear a fake that cost you $30? Rolex didn&amp;#8217;t really lose [...]
      CommentsBut your brain doesn't always know it knows!  Good point, ... by Roger DooleyThe brain has an error detection mechanism that registers when ... by David Krueger MD (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3965501</comments>
            <pubDate>Mon, 13 Sep 2010 12:27:32 +0100</pubDate>
            <guid isPermaLink="false">3965501</guid>        </item>
        <item>
            <title>A Biomedical Look At Spaceflight</title>
            <link>http://www.medworm.com/index.php?rid=3913123&amp;cid=t_117220_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fa-biomedical-look-at-spaceflight%2F2010.08.28</link>
            <description>Book review by Dan Buckland
(Dan Buckland is an editor at Medgadget and an MD/PhD student at Harvard Med/MIT whose thesis deals with diagnosing back injury in spaceflight using ultrasound.)
Mary Roach, author of previous entertaining books Bonk (a history of sex research) and Stiff (a history of cadaver research), has turned her considerable talents in translating decades of research into a readable review of human (and animal) spaceflight experimentation.
The title of her new book, Packing for Mars: The Curious Science of Life in the Void, is a bit of a misnomer &amp;#8212; only the last chapter is devoted to the medical advances needed for a trip to Mars. However, it is a great layman&amp;#8217;s history of the biomedical results of both the American and Russian space programs.
Through my own re...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3913123</comments>
            <pubDate>Sat, 28 Aug 2010 13:00:58 +0100</pubDate>
            <guid isPermaLink="false">3913123</guid>        </item>
        <item>
            <title>A Clinical Trial, A Suicide And Patient Safety</title>
            <link>http://www.medworm.com/index.php?rid=3899634&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FQV82PczRStE%2F</link>
            <description>What happens when a university is bound up in the outcome of an industry clinical trial? What does it say when university researchers are actively recruiting patients for a trial while also accepting consulting or speaking fees from the same drugmaker sponsoring the study? Is the research furthering commercial needs more so than scientific needs? And how are patients protected in such situations?
These are among the questions explored in a sobering piece in Mother Jones magazine by University of Minnesota bioethicist Carl Elliott. He focuses on the sorry plight of Mary Weiss, who lost her 26-year-old son, Dan, while he was enrolled - over her strenuous objections - in a trial at the University of Minnesota (yes, the same school) to compare AstraZeneca&amp;#8217;s Seroquel antipsychotic with ri...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3899634</comments>
            <pubDate>Tue, 24 Aug 2010 13:58:26 +0100</pubDate>
            <guid isPermaLink="false">3899634</guid>        </item>
        <item>
            <title>&quot;Diabetes Rising&quot; by Dan Hurley</title>
            <link>http://www.medworm.com/index.php?rid=3896050&amp;cid=t_117220_134_f&amp;fid=35187&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FDiabetesDaily%2F%7E3%2FIa9lS3CUQLI%2Fdiabetes-rising-by-dan-hurley.php</link>
            <description>I first heard of Dan Hurley and his book, &quot;Diabetes Rising&quot;, over at Amy's site (Diabetes Mine). She did a two part interview about a year ago (Part 1, Part 2), and there was something about what Dan said that pulled at my emotions.&amp;nbsp; He says about his approach to the book:... Even with this best medical advice, I feel that 
the just try harder approach is not going to work for a lot of people.
 If youre very educated, motivated, and have a good attitude, you can 
kind of stumble your way through it. But obviously tons and tons of 
people dont have all those attributes something else is needed to help
 them. How many times have you felt you needed to &quot;just try harder?&quot;&amp;nbsp; Or worse yet, been told you &quot;just need to try harder?&quot;&amp;nbsp; I feel that way almost all the time!&amp;nbsp...</description>
            <author>Diabetes Daily</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3896050</comments>
            <pubDate>Mon, 23 Aug 2010 13:00:00 +0100</pubDate>
            <guid isPermaLink="false">3896050</guid>        </item>
        <item>
            <title>Mistakes Were Made (but not by me)</title>
            <link>http://www.medworm.com/index.php?rid=3942846&amp;cid=t_117220_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F19002543%2F0%2Fneuromarketing%7EMistakes-Were-Made-but-not-by-me.htm</link>
            <description>The imperfection of our human brains has been a frequent topic of books lately, most notably Dan Ariely’s Predictably Irrational. Mistakes were made goes into considerable depth on one key failing, cognitive dissonance. The authors call cognitive dissonance the “engine of self-justification” and attribute many examples of irrational behavior to our attempts to resolve it.
      Comments[...] grandfather smoked until he was 95 and was always ... by Doctor Disruption &amp;#187; The Engine of Self Justification (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3942846</comments>
            <pubDate>Thu, 19 Aug 2010 12:53:23 +0100</pubDate>
            <guid isPermaLink="false">3942846</guid>        </item>
        <item>
            <title>Surgeon Dr. Dan Benishek Wins GOP Primary in Michigan</title>
            <link>http://www.medworm.com/index.php?rid=3872493&amp;cid=t_117220_83_f&amp;fid=34856&amp;url=http%3A%2F%2Finsidesurgery.com%2F2010%2F08%2Fsurgeon-dr-dan-benishek-wins-gop-primary-michigan%2F</link>
            <description>Surgeon Dr. Dan Benishek has won the GOP Primary in Michigan&amp;#8217;s 1st district by 15 votes and now his opponent State Sen. Jason Allen has decided to concede the contest and not seek a costly and prolonged recount. (Source: Inside Surgery)</description>
            <author>Inside Surgery</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3872493</comments>
            <pubDate>Tue, 17 Aug 2010 01:12:15 +0100</pubDate>
            <guid isPermaLink="false">3872493</guid>        </item>
        <item>
            <title>Should Obama Bypass Senate to Appoint Health Care Official?</title>
            <link>http://www.medworm.com/index.php?rid=3733053&amp;cid=t_117220_87_f&amp;fid=36050&amp;url=http%3A%2F%2Fblisstree.com%2Flive%2Fshould-obama-bypass-senate-to-appoint-health-care-official%2F</link>
            <description>President Obama announced yesterday that he will bypass congress to appoint Dr. Donald M. Berwick as administrator of the Centers for Medicare and Medicaid Services. The decision, called a &amp;#8220;recess appointment&amp;#8221;, is going through while senate is in recess, which many find surprising because it&amp;#8217;s only in recess for a short amount of time.
White House communications director Dan Pfeiffer said that the appointment is needed to carry out the new health care law, which calls for big changes in both Medicare and Medicaid, affecting about 1/3 of all Americans. The New York Times quoted his statement that &amp;#8220;many Republicans in Congress have made it clear in recent weeks that they were going to stall the nomination as long as they could, solely to score political points.&amp;#8221;...</description>
            <author>Breastfeeding 1-2-3</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3733053</comments>
            <pubDate>Wed, 07 Jul 2010 19:33:41 +0100</pubDate>
            <guid isPermaLink="false">3733053</guid>        </item>
        <item>
            <title>Musings From A Member Of The Medical Class Of 2010</title>
            <link>http://www.medworm.com/index.php?rid=3644764&amp;cid=t_117220_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fmusings-from-a-member-of-the-medical-class-of-2010%2F2010.06.09</link>
            <description>As a medical student in his last year, I can attest that my classmates and I would like nothing less than a crystal ball. Always a daunting time in a future physician’s career path, the direction we point ourselves as we launch out of medical school this year seems as arbitrary as ever.
As we examine the rolling seas of medicine and try to determine our individual paths, there seem to be more clouds than blue skies, and certainly more shadows than light. This may or may not be a feeling many prospective physicians feel, but for the class of 2010 it comes as a tough pill to swallow. In a profession at the heart of a national policy debate and with a storied history to examine, it’s extremely disconcerting to be faced with so many question marks. (more&amp;#8230;) (Source: Better Health)</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3644764</comments>
            <pubDate>Wed, 09 Jun 2010 12:00:36 +0100</pubDate>
            <guid isPermaLink="false">3644764</guid>        </item>
        <item>
            <title>Californians Challenge Pay-To-Delay Deals</title>
            <link>http://www.medworm.com/index.php?rid=3577626&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fh_IpIo82H4Y%2F</link>
            <description>A federal appeals court last month may have upheld the legality of pay-for-delay deals that thwart the introduction of generics, but the issue isn&amp;#8217;t dead yet. A group of consumers, union health and welfare funds, which have been certified as a class, are asking a California appeals court to review the same set of circumstances involving Bayer, Barr Pharmaceuticals and the Cipro antibiotic.
At issue in both cases is a deal in which Bayer paid Barr, now owed by Teva Pharmaceuticals, to drop its 1991 patent challenge to Cipro. In 1997, Barr struck a deal with Bayer just two weeks before a lawsuit was set to go to trial, delaying the entrance of a generic version. The US Second Circuirt Court of Appeals ruled the deal was kosher (see here), although the Federal Trade Commission continues...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3577626</comments>
            <pubDate>Wed, 19 May 2010 12:11:47 +0100</pubDate>
            <guid isPermaLink="false">3577626</guid>        </item>
        <item>
            <title>NFIB: ObamaCare Is Unconstitutional, ‘Threatens Individual Freedom’</title>
            <link>http://www.medworm.com/index.php?rid=3563947&amp;cid=t_117220_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2F1neoU6wqqj4%2F</link>
            <description>By Michael F. CannonThe National Federation of Independent Business — the nation&amp;#8217;s largest small-business lobby — will join the lawsuit that 20 attorneys general (including one Democrat) have brought against ObamaCare. 
According to the Associated Press, NFIB found ObamaCare&amp;#8217;s individual mandate particularly offensive:
The National Federation of Independent Business will join the argument that Americans cannot be required under the Constitution to obtain insurance coverage, the group&amp;#8217;s president, Dan Danner, said in an interview&amp;#8230;
The new law allows government &amp;#8220;to regulate you just because you exist,&amp;#8221; said Danner. &amp;#8220;If you can regulate this, where do you stop? Do you tell people, &amp;#8216;We are going to mandate that everybody exercise?&amp;#8217; W...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3563947</comments>
            <pubDate>Fri, 14 May 2010 13:20:56 +0100</pubDate>
            <guid isPermaLink="false">3563947</guid>        </item>
        <item>
            <title>Leaves Lady Gaga in the Dust</title>
            <link>http://www.medworm.com/index.php?rid=3556073&amp;cid=t_117220_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FH8aQYegPHXs%2F</link>
            <description>By Jim HarperIn their 2006 Cato Policy Analysis, &amp;#8220;Amateur-to-Amateur: The Rise of a New Creative Culture,&amp;#8221; Gregory Lastowka and Dan Hunter wrote about how the functions that make up the creative cycle&amp;#8212;creation, selection, production, dissemination, promotion, sale, and use of expressive content&amp;#8212;are undergoing revolutionary decentralization and disintermediation.
The only thing professional in the clip below was the writing of the song. It deserves its credit, but the performance itself, production of the video, its selection, dissemination, and promotion (Twitter users, YouTube) are all amateur or amateur supported by a professionally managed, ad-supported platform.

Watch it a second time to take in the reactions of the girls sitting in front of the map. If you lik...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3556073</comments>
            <pubDate>Wed, 12 May 2010 12:40:07 +0100</pubDate>
            <guid isPermaLink="false">3556073</guid>        </item>
        <item>
            <title>Trust Me: You’ll Enjoy this Post</title>
            <link>http://www.medworm.com/index.php?rid=3490694&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2010%2F04%2F21%2Ftrust-me-youll-enjoy-this-post%2F</link>
            <description>Craig Lambert has a worthwhile interview with Situationist friend, Dan Gilbert (author of the best-selling 2007 psychology book Stumbling  on Happiness and host of the recent PBS television series This Emotional Life.), in the current issue of Harvard Magazine.   Here are some excerpts.
* * *

In a recent issue of Science, Gilbert and his coauthors—psychology graduate student Matthew Killingsworth, Rebecca Eyre, Ph.D. ’05, and [Situationist Contributor] Timothy Wilson, Aston professor of psychology at the University of Virginia—reported findings on “surrogation”: consulting the experience of another person, a surrogate, in deciding whether something will make you happy. They discovered that the direct experience of another person trumps the conjecturing of our own minds.
The sur...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3490694</comments>
            <pubDate>Wed, 21 Apr 2010 04:01:20 +0100</pubDate>
            <guid isPermaLink="false">3490694</guid>        </item>
        <item>
            <title>---</title>
            <link>http://www.medworm.com/index.php?rid=3487276&amp;cid=t_117220_131_f&amp;fid=34989&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FGeneticsHealth%2F%7E3%2FY6kk-AP1LUY%2F</link>
            <description>Google Wants to Price Your Carbon: Dan Reicher, Google&amp;#8217;s director of climate change and energy initiatives, argues that carbon pricing is good for the climate and for business. (On Planet Green&amp;#8217;s video news)
Post from: BlissTree (Source: Genetics and Health)</description>
            <author>Genetics and Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3487276</comments>
            <pubDate>Tue, 20 Apr 2010 18:09:53 +0100</pubDate>
            <guid isPermaLink="false">3487276</guid>        </item>
        <item>
            <title>Former Sex Bloggers Confront Mommyhood – and Blogging About It</title>
            <link>http://www.medworm.com/index.php?rid=3460137&amp;cid=t_117220_87_f&amp;fid=36050&amp;url=http%3A%2F%2Fblisstree.com%2Flive%2Fformer-sex-bloggers-confront-mommyhood-%25e2%2580%2593-and-blogging-about-it%2F</link>
            <description>This article originally appeared on our sister site, TheGloss.
The sex column has mutated mightily since the earliest days of &amp;#8220;Ask Anka&amp;#8221; in Details. Once banished to the back section of alt-weeklies, right by the classified ads, frank first-person sex writing has spread to college newspapers and blogs.
And ad as this world has matured, so have its participants. So what happens when writers decide that they want to focus their erotic energies on one person, or just that they need to take a break from chronicling their intimate exploits? Some writers go the eminent-sage route, moving into a position where they dole out advice to the needy. But others, including the acid-tongued New York City dating columnist Amy Sohn and the pioneering sex website Nerve, are moving on to a step t...</description>
            <author>Breastfeeding 1-2-3</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3460137</comments>
            <pubDate>Mon, 12 Apr 2010 15:03:09 +0100</pubDate>
            <guid isPermaLink="false">3460137</guid>        </item>
        <item>
            <title>Dan Wegner on “Psychological Studies of the Guilty Mind”</title>
            <link>http://www.medworm.com/index.php?rid=3411151&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2010%2F03%2F27%2Fdan-wegner-on-psychological-studies-of-the-guilty-mind%2F</link>
            <description>From the Student Association for Law and Mind Sciences (SALMS) and the Project on Law and Mind Sciences (PLMS) at Harvard Law School, here is an remarkable presentation, titled “Psychological Studies of the Guilty Mind,&amp;#8221; by Dan Wegner, one of the most thoughtful and influential social psychologists in the business.
* * *

* * *
To review a collection of Situationist posts discussing Dan Wegner&amp;#8217;s research, click here. (Source: The Situationist)</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3411151</comments>
            <pubDate>Sat, 27 Mar 2010 04:01:54 +0100</pubDate>
            <guid isPermaLink="false">3411151</guid>        </item>
        <item>
            <title>Kids' Music That Doesn't Suck</title>
            <link>http://www.medworm.com/index.php?rid=3385333&amp;cid=t_117220_87_f&amp;fid=36050&amp;url=http%3A%2F%2Fblisstree.com%2Flive%2Fkids-music-that-doesnt-suck%2F</link>
            <description>Music for kids is great and all, but how many rounds of “Row, Row, Row Your Boat” can you endure before wanting to drive the car over a cliff? Blisstree found five tolerable toddler-friendly albums, so pump up the volume:
Barenaked Ladies – &amp;#8220;Snack Time&amp;#8221;
Karen O and the Kids – &amp;#8220;Where the Wild Things Are&amp;#8221; Motion Picture Soundtrack
&amp;#8220;Spongebob Squarepants&amp;#8221; Motion Picture Soundtrack (Various Artists)
Dan Zanes – 76 Trombones
Putumayo – World Playgrounds 1 &amp; 2
Post from: BlissTree (Source: Breastfeeding 1-2-3)</description>
            <author>Breastfeeding 1-2-3</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3385333</comments>
            <pubDate>Fri, 19 Mar 2010 21:59:55 +0100</pubDate>
            <guid isPermaLink="false">3385333</guid>        </item>
        <item>
            <title>The Situation of the Health Care Debate</title>
            <link>http://www.medworm.com/index.php?rid=3366277&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2010%2F03%2F14%2Fthe-situation-of-the-health-care-debate%2F</link>
            <description>A Harvard Law student wrote a worthwhile post on Law &amp; Mind a few weeks ago about some of the dynamics behind the health care debate.  Here is an excerpt.
* * *
How should an institution inspire collective action?  What’s the best strategy?  The conventional wisdom is that to solve a collective problem, the institution should reward contributors and punish free-riders.  To prevent people from littering, fine them; to induce people to donate to charity, reward them; to move people to invent, lure them with intellectual property . . . .  The implicit reasoning is that the typical human agent is a rational wealth-optimizer who won’t contribute to a public good unless he or she is incentivized to do.  Yet, . . . the rational actor model isn’t an accurate depiction of human natu...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3366277</comments>
            <pubDate>Mon, 15 Mar 2010 03:27:41 +0100</pubDate>
            <guid isPermaLink="false">3366277</guid>        </item>
        <item>
            <title>Rethinking a ‘Cure’ for Diabetes?</title>
            <link>http://www.medworm.com/index.php?rid=3331524&amp;cid=t_117220_134_f&amp;fid=34841&amp;url=http%3A%2F%2Fwww.diabetesmine.com%2F2010%2F03%2Frethinking-a-%25e2%2580%2598cure%25e2%2580%2599-for-diabetes.html</link>
            <description>Dan Hurley, award-winning journalist and author of the new book Diabetes Rising is turning out to have some controversial views. He certainly thinks about Type 1 diabetes — which he&amp;#8217;s lived with himself for 34 years — in different terms than I do; he&amp;#8217;s very focused on causes and prevention, while I&amp;#8217;m just trying to [...] (Source: Diabetes Mine)</description>
            <author>Diabetes Mine</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3331524</comments>
            <pubDate>Thu, 04 Mar 2010 13:00:04 +0100</pubDate>
            <guid isPermaLink="false">3331524</guid>        </item>
        <item>
            <title>The Return of Dan Coats</title>
            <link>http://www.medworm.com/index.php?rid=3294574&amp;cid=t_117220_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2Fbk15vkXHtMY%2F</link>
            <description>By David BoazFormer Indiana senator Dan Coats is running for his old seat again, 12 years after he left Congress and turned the seat over the now-retiring Evan Bayh.  Coats says he&amp;#8217;s very concerned that &amp;#8220;our elected officials in Washington continue to run up massive deficits, recklessly borrowing and spending record amounts of taxpayer money with no regard for the future generations of Americans who will inherit this staggering and ever-increasing debt,&amp;#8221; and he has the support of conservative congressional leader Mike Pence. But I remember a Senator Dan Coats who enthusiastically promoted big, paternalist government. In the Heritage Foundation&amp;#8217;s Policy Review, I responded to a Coats essay on his &amp;#8220;Project for American Renewal,&amp;#8221; launched with Bill Bennett...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3294574</comments>
            <pubDate>Mon, 22 Feb 2010 15:00:23 +0100</pubDate>
            <guid isPermaLink="false">3294574</guid>        </item>
        <item>
            <title>A Must Watch!</title>
            <link>http://www.medworm.com/index.php?rid=3262658&amp;cid=t_117220_109_f&amp;fid=34786&amp;url=http%3A%2F%2Fdrmichelletempest.blogspot.com%2F2010%2F02%2Fmust-watch.html</link>
            <description>Dan Hannan another author in 'The Future of the NHS' has this to say: (Source: The Psychiatrist Blog)</description>
            <author>The Psychiatrist Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3262658</comments>
            <pubDate>Thu, 11 Feb 2010 13:15:00 +0100</pubDate>
            <guid isPermaLink="false">3262658</guid>        </item>
        <item>
            <title>Ketchup And Drugs Have What In Common?</title>
            <link>http://www.medworm.com/index.php?rid=3254721&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FUFmm7ug15Jo%2F</link>
            <description>The answer is Joe Jimenez. When he was first named to run the Novartis pharmaceutical business in 2007, Jimenez liked to talk about key account management, which is how a packaged-goods company views its relationship with a retailer. That wasn&amp;#8217;t terribly surprising, given that he had spent eight years at Heinz, where he oversaw the introduction of green ketchup for kids, among other things.
Somehow, the analogy still stands, in so far as speed is of the essence. Recently promoted to succeed Dan Vasella as the drugmaker&amp;#8217;s ceo, Jimenez is still reaching back to his consumer products days for lessons on running Novartis. With consumer packaged goods, &amp;#8220;decisions have to be made quickly because the market moves quickly,&amp;#8221; he tells Bloomberg News. But drugmakers have long ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3254721</comments>
            <pubDate>Tue, 09 Feb 2010 12:37:03 +0100</pubDate>
            <guid isPermaLink="false">3254721</guid>        </item>
        <item>
            <title>Novartis To Give Vasella Too Much Of A Bonus</title>
            <link>http://www.medworm.com/index.php?rid=3239816&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F7G2Na5ih3kI%2F</link>
            <description>Former Novartis ceo Dan Vasella&amp;#8217;s 2009 bonus will be close to three times the amount he would be due based on relative earnings growth among large cap peers, according to a report compiled by UK proxy voting agency Manifest and Swiss consultancy Obermatt, Reuters writes.
The estimated payout will total about $5.96 million. And that would be around $3.8 millionabove the maximum level calculated by Obermatt, which bases its bonus recommendation on the number of peers a company outperforms - the more peers are beaten, the higher the bonus. Novartis couldn&amp;#8217;t confirm the estimated bonus level for 2009. &amp;#8220;Dr. Vasella&amp;#8217;s base as well as total compensation is in line with that of CEOs from other large healthcare companies,&amp;#8221; a Novartis spokeswoman tells Reuters.
Vasella ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3239816</comments>
            <pubDate>Wed, 03 Feb 2010 18:02:49 +0100</pubDate>
            <guid isPermaLink="false">3239816</guid>        </item>
        <item>
            <title>Wayback Wednesday: Confounded (Diabetes) Statistics</title>
            <link>http://www.medworm.com/index.php?rid=3236023&amp;cid=t_117220_134_f&amp;fid=34841&amp;url=http%3A%2F%2Fwww.diabetesmine.com%2F2010%2F02%2Fwayback-wednesday-confounded-diabetes-statistics.html</link>
            <description>Today, another example of the more things change, the more they stay the same:
 In his new book Diabetes Rising, journalist Dan Hurley reports about skyrocketing numbers of children being diagnosed with Type 1 diabetes in a wealthy Boston suburb. Parents there are desperate for answers as to why this is happening, yet &amp;#8220;the lack [...] (Source: Diabetes Mine)</description>
            <author>Diabetes Mine</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3236023</comments>
            <pubDate>Wed, 03 Feb 2010 13:00:59 +0100</pubDate>
            <guid isPermaLink="false">3236023</guid>        </item>
        <item>
            <title>iPhone App Saved Earthquake Victim’s Life</title>
            <link>http://www.medworm.com/index.php?rid=3212285&amp;cid=t_117220_87_f&amp;fid=34872&amp;url=http%3A%2F%2Fwww.blisstree.com%2Fhealthbolt%2Fiphone-app-saved-earthquake-victims-life%2F</link>
            <description>You just never know what your iPhone will do for you &amp;#8211; and the next time someone comments on the cost or extravagance of your iPhone, tell them that if you want to try to save a life, there&amp;#8217;s an app for that.
apple.com
According to a Yahoo.com story, American film-maker Dan Woolley, who was in Haiti to make a documentary on poverty in that country&amp;#8217;s capital, Port-au-Prince, was trapped beneath rubble after the hotel he was staying in collapsed. Unable to get help, Woolley was trapped with a broken leg and a bleeding head wound.
Although a fractured leg is serious, a head wound can be much more so. Just remember actress Natasha Richardson&amp;#8217;s death after she fell and struck her head while on a ski hill. The bleeding also needed to be stopped. So, what to do?
Using the ...</description>
            <author>Healthbolt</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3212285</comments>
            <pubDate>Wed, 27 Jan 2010 13:31:22 +0100</pubDate>
            <guid isPermaLink="false">3212285</guid>        </item>
        <item>
            <title>Dan Kahan on the Situation of Risk Perceptions</title>
            <link>http://www.medworm.com/index.php?rid=3212393&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2010%2F01%2F27%2Fdan-kahan-on-the-situation-of-risk-perceptions%2F</link>
            <description>Situationist Contributor Dan Kahan was recently interviewed for the National Science Foundation website.  In the interview, which you can watch the on the video below, Kahan discusses how people&amp;#8217;s values shape perceptions of the HPV vaccine.  Here&amp;#8217;s the abstract.
* * * 
The &amp;#8220;cultural cognition thesis&amp;#8221; argues that individuals form risk perceptions based on often-contested personal views about what makes a good society. Now, Yale University Law professor Dr. Dan Kahan and his colleagues reveals how people&amp;#8217;s values shape their perceptions of one of the most hotly debated health care proposals in recent years: vaccinating elementary-school girls, ages 11-12, against human papillomavirus (HPV), a widespread sexually transmitted disease.

 * * *



* * *
For a sam...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3212393</comments>
            <pubDate>Wed, 27 Jan 2010 04:01:46 +0100</pubDate>
            <guid isPermaLink="false">3212393</guid>        </item>
        <item>
            <title>Vasella Steps Aside As Novartis CEO</title>
            <link>http://www.medworm.com/index.php?rid=3208687&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FtuFCdpv_JR8%2F</link>
            <description>Implementing a succession plan he claims to have hatched a year ago, Dan Vasella is stepping aside as ceo and will be succeeded by Joe Jimenez, who currently heads the Novartis pharma biz. Vasella, however, will remain chairman. Meanwhile, Joerg Reinhardt, who less than two years ago was named chief operating officer (see here) and was widely believed to have been the next ceo, is leaving altogether. 
The other changes: David Epstein, who currently heads the oncology business, will now run the pharma biz; Jon Symonds will replace the retiring Raymund Breu as cfo; and the executive committee will shrink from 12 to 9. The Novartis 9 includes Jimenez; Epstein; Symonds; Mark Fishman, global head of the Novartis Institute for BioMedical Research; Jeff George, who runs generics; George Gunn, who...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3208687</comments>
            <pubDate>Tue, 26 Jan 2010 12:10:35 +0100</pubDate>
            <guid isPermaLink="false">3208687</guid>        </item>
        <item>
            <title>Haiti Relief: A Mindful Dialogue</title>
            <link>http://www.medworm.com/index.php?rid=3208447&amp;cid=t_117220_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2010%2F01%2F25%2Fhaiti-relief-a-mindful-dialogue%2F</link>
            <description>I know many of you have already given to charities in order to help Haiti. Today, as the crisis enters its third week, I ask that you consider giving a little more&amp;#8230;
A Mindful Dialogue is a new e-book edited by our blogger Elisha Goldstein, Ph.D. and that was written to be a companion through life when dealing with stress, pain and difficult emotions. Through 24 interviews with leaders in the field such as Jack Kornfield, Dan Siegel, Sharon Salzberg, Tara Brach, Jeff Brantley, Zindel Segal and Others and 23 short explorations of simple quotes from leaders such as Thich Nhat Hanh, the Dalai Lama, Rumi, Hafiz, Pema Chodron and Others, you&amp;#8217;ll uncover a mindful path toward working with the stress, pain and difficult emotions in daily life.
100% of the proceeds will go to HOPE FOR HA...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3208447</comments>
            <pubDate>Mon, 25 Jan 2010 20:05:31 +0100</pubDate>
            <guid isPermaLink="false">3208447</guid>        </item>
        <item>
            <title>Win A Copy of “Diabetes Rising”</title>
            <link>http://www.medworm.com/index.php?rid=3182326&amp;cid=t_117220_134_f&amp;fid=34841&amp;url=http%3A%2F%2Fwww.diabetesmine.com%2F2010%2F01%2Fwin-a-copy-of-diabetes-rising.html</link>
            <description>A little diabetes online fun for your Monday: Use your Noggin and three lucky readers will win a free copy of Dan Hurley&amp;#8217;s new &amp;#8220;epic&amp;#8221; book, &amp;#8220;Diabetes Rising.&amp;#8221;
First off, you may have heard a lot of buzz about this book lately. The full title is, &amp;#8220;Diabetes Rising: How a Rare Disease Became a Modern Pandemic, [...] (Source: Diabetes Mine)</description>
            <author>Diabetes Mine</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3182326</comments>
            <pubDate>Mon, 18 Jan 2010 14:00:13 +0100</pubDate>
            <guid isPermaLink="false">3182326</guid>        </item>
        <item>
            <title>Vasella To Animal Rights Groups: Dialogue, Not Crime</title>
            <link>http://www.medworm.com/index.php?rid=3108547&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FVMFUskz4orM%2F</link>
            <description>Animal rights activists regularly go after the pharmaceutical industry, but they made big headlines last summer when some visited the hometown of Novartis ceo Dan Vasella and painted &amp;#8220;murderer&amp;#8221; on the church, desecrated the graves of his sister and parents, and set fire to his Austrian vacation home. Vasella spoke with USA Today about the episode and his reaction.
USA Today: Aren&amp;#8217;t you helping activists by giving them the soapbox they desire?
Vasella: I don&amp;#8217;t believe so. It&amp;#8217;s my duty as a citizen to speak up when illegal actions take place. Suffering in silence doesn&amp;#8217;t help anybody. You have to stand up. You have to fight for something. If everyone remained silent, then the people who are violent would prevail.
USA Today: Aren&amp;#8217;t you putting a bull&amp;...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3108547</comments>
            <pubDate>Mon, 21 Dec 2009 12:25:36 +0100</pubDate>
            <guid isPermaLink="false">3108547</guid>        </item>
        <item>
            <title>Smartphone adoption trend draws mobile app, content developers</title>
            <link>http://www.medworm.com/index.php?rid=3044850&amp;cid=t_117220_113_f&amp;fid=38236&amp;url=http%3A%2F%2Fwww.healthcareitnews.com%2Fblog%2Fsmartphone-adoption-trend-draws-mobile-app-content-developers</link>
            <description>With a recent Manhattan Research report claiming 81 percent of physicians will own smartphones by 2012, the race is on to develop mobile applications and customized content aimed at physicians and allied health professionals. Most recently, two companies with a track record for providing and distributing medical content have teamed up to produce new health-based apps. (Source: Healthcare IT News Blog)</description>
            <author>Healthcare IT News Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3044850</comments>
            <pubDate>Tue, 01 Dec 2009 15:14:14 +0100</pubDate>
            <guid isPermaLink="false">3044850</guid>        </item>
        <item>
            <title>The Situation of Cheating</title>
            <link>http://www.medworm.com/index.php?rid=3017104&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2009%2F11%2F22%2Fthe-situation-of-cheating%2F</link>
            <description>Behavioral economist Dan Ariely, in the following video, describes one of his fascinating studies on the situation of cheating.
* * *

* * *
For a sample of related Situationist posts, see &amp;#8220;The Interior Situation of Honesty (and Dishonesty),&amp;#8221; “The Situation of Lying,” “The Facial Obviousness of Lying,” “Cheating Doesn’t Pay . . . So Why So Much of it?,” &amp;#8220;Dan Ariely, a Situationist,&amp;#8221; “Dan Ariely on Cheating,”and “Unclean Hands.&amp;#8221; (Source: The Situationist)</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3017104</comments>
            <pubDate>Sun, 22 Nov 2009 04:01:15 +0100</pubDate>
            <guid isPermaLink="false">3017104</guid>        </item>
        <item>
            <title>Who Is Switzerland’s Highest-Paid CEO? Vasella!</title>
            <link>http://www.medworm.com/index.php?rid=2989406&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FJLhTlq5XXQc%2F</link>
            <description>The man who once told his shareholders he is the equivalent of a cheap date (in so many words) is also the highest-paid exec in Switzerland, according to a list published by Handelszeitung, the Swiss business journal (Swisster has translated for us).
The newspaper writes that the pay given Novartis ceo Dan Vasella jumped by more than 20 percent in 2008 to 20.5 million francs. Dan is regularly criticized for serving as chairman and ceo by shareholder groups who would like to see the roles split in order to provide more oversight. But Dan has been arguing that he actually saves them money - separating the two jobs would be inefficient and costly.
Hmmm&amp;#8230;&amp;#8230;Meanwhile, the list ranks Roche chairman Franz Hummer in third place, although his income dropped 30 percent to 15.2 million fran...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2989406</comments>
            <pubDate>Fri, 13 Nov 2009 13:06:14 +0100</pubDate>
            <guid isPermaLink="false">2989406</guid>        </item>
        <item>
            <title>Novartis Gives Thumbs Down To R&amp;D In India</title>
            <link>http://www.medworm.com/index.php?rid=2985035&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FvtQoz7Em2jw%2F</link>
            <description>Frustrated with patent challenges, Novartis has put its R&amp;#038;D activities in India on the back burner, The Economic Times reports. Chief executive Dan Vasella, who was in Mumbai to attend a Pepsico board meeting, tells the paper that intellectual property protection in India is not what it ought to be.
 “In principle you can discover in India, you can do research. There has been some progress on the protection of intellectual property but its not up to the standard that I would expect to make an investment into discovery led research,” Vasella tells the paper. 
He adds that India&amp;#8217;s recent decision to invest $1 billion in China and not India was not driven by its bad experience with its Gleevec cancer drug in India but a friendler investment environment in China. Novartis, you m...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2985035</comments>
            <pubDate>Thu, 12 Nov 2009 13:26:51 +0100</pubDate>
            <guid isPermaLink="false">2985035</guid>        </item>
        <item>
            <title>Dan Gilbert on Why the Brain Scares Itself</title>
            <link>http://www.medworm.com/index.php?rid=2971942&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2009%2F11%2F08%2Fdan-gilbert-on-why-the-brain-scares-itself%2F</link>
            <description>For the Harvard Law Record, Harvard Law Students, Anush Emelianova and Gustavo Ribeiro, wrote a nice summary of Dan Gilbert&amp;#8217;s recent lecture at Harvard Law School.  His lecture, titled &amp;#8220;Why Does the Brain Scare Itself?,&amp;#8221; drew a  crowd of roughly 150 students and contributed to Gilbert&amp;#8217;s reputation as an amazing and captivating speaker.    Here&amp;#8217;s Emilianova and Ribeiro&amp;#8217;s description.
* * *
Why does the brain scare itself?  On Monday, October 19, Professor Dan Gilbert confronted this question in an event sponsored by first-year Section VI. Professor Gilbert, who wrote  the bestselling book Stumbling on Happiness, is a Professor of Psychology at Harvard University and the Director of Harvard’s Hedonic Psychology Laboratory. He opened his remarks by ...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2971942</comments>
            <pubDate>Sun, 08 Nov 2009 15:12:41 +0100</pubDate>
            <guid isPermaLink="false">2971942</guid>        </item>
        <item>
            <title>The Painful Situation of Guilt</title>
            <link>http://www.medworm.com/index.php?rid=2931052&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2009%2F10%2F27%2Fthe-painful-situation-of-guilt%2F</link>
            <description>From Eureka Alert:
The rationale behind torture is that pain will make the guilty confess, but a new study by researchers at Harvard University finds that the pain of torture can make even the innocent seem guilty.
Participants in the study met a woman suspected of cheating to win money. The woman was then &amp;#8220;tortured&amp;#8221; by having her hand immersed in ice water while study participants listened to the session over an intercom. She never confessed to anything, but the more she suffered during the torture, the guiltier she was perceived to be.
The research, published in the &amp;#8220;Journal of Experimental Social Psychology,&amp;#8221; was conducted by Kurt Gray, graduate student in psychology, and Daniel M. Wegner, professor of psychology, both in Harvard&amp;#8217;s Faculty of Arts and Scien...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2931052</comments>
            <pubDate>Tue, 27 Oct 2009 04:01:29 +0100</pubDate>
            <guid isPermaLink="false">2931052</guid>        </item>
        <item>
            <title>Dan Gilbert on the Situation of Our Decisions</title>
            <link>http://www.medworm.com/index.php?rid=2904947&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2009%2F10%2F19%2Fdan-gilbert-on-the-situation-of-our-decisions%2F</link>
            <description>Situationist friend Dan Gilbert, who will be speaking today at Harvard Law School (details here), recently completed another fascinating TedTalk. Here is their summary:   &amp;#8220;Dan Gilbert presents research and data from his exploration of happiness &amp;#8212; sharing some surprising tests and experiments that you can also try on yourself. Watch through to the end for a sparkling Q&amp;A with some familiar TED faces.&amp;#8221;  Here&amp;#8217;s the video.

* * *


* * *
For a sample of previous Situationist posts by or about Dan Gilbert and his work, see &amp;#8220;The Situational Consequences of Uncertainty,&amp;#8221; &amp;#8220;Dan Gilbert on the Situation of Psychology,&amp;#8221; &amp;#8220;Something to Smile About,&amp;#8221; &amp;#8220;The Situation of Climate Change,&amp;#8221; “The Heat is On,” &amp;#8220;Don’t ...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2904947</comments>
            <pubDate>Mon, 19 Oct 2009 04:15:02 +0100</pubDate>
            <guid isPermaLink="false">2904947</guid>        </item>
        <item>
            <title>Dan Gilbert To Speak at Harvard Law School</title>
            <link>http://www.medworm.com/index.php?rid=2902826&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2009%2F10%2F18%2Fdan-gilbert-to-speak-at-harvard-law-school%2F</link>
            <description>For more details, click here. (Source: The Situationist)</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2902826</comments>
            <pubDate>Sun, 18 Oct 2009 04:01:32 +0100</pubDate>
            <guid isPermaLink="false">2902826</guid>        </item>
        <item>
            <title>Dan Hurley on Diabetes, Part 2: “Transformative Technology”</title>
            <link>http://www.medworm.com/index.php?rid=2851996&amp;cid=t_117220_134_f&amp;fid=34841&amp;url=http%3A%2F%2Fwww.diabetesmine.com%2F2009%2F10%2Fdan-hurley-on-diabetes-part-2-transformative-technology.html</link>
            <description>Welcome to Part 2 of my talk with award-winning journalist and Type 1 diabetic Dan Hurley, whose new &amp;#8220;epic book&amp;#8221; Diabetes Rising is due out soon.  In case you missed it, read Part 1 of the interview here.  Today, Dan talks about achieving the impossible — an artificial pancreas that works, and a diabetes [...] (Source: Diabetes Mine)</description>
            <author>Diabetes Mine</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2851996</comments>
            <pubDate>Thu, 01 Oct 2009 16:40:46 +0100</pubDate>
            <guid isPermaLink="false">2851996</guid>        </item>
        <item>
            <title>Author Dan Hurley on Diabetes, Part 1: “Try Harder” is Not Enough!</title>
            <link>http://www.medworm.com/index.php?rid=2842729&amp;cid=t_117220_134_f&amp;fid=34841&amp;url=http%3A%2F%2Fwww.diabetesmine.com%2F2009%2F09%2Fauthor-dan-hurley-on-diabetes-part-1-try-harder-is-not-enough.html</link>
            <description>Dan Hurley is a journalist and science writer who contributes regularly to the New York Times.  He&amp;#8217;s also written for the Medical Tribune and Psychology Today.  And he&amp;#8217;s one of us PWDs.  His new book, Diabetes Rising, is an exposé on the academic world of diabetes, coming out January. Have a look at last week&amp;#8217;s [...] (Source: Diabetes Mine)</description>
            <author>Diabetes Mine</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2842729</comments>
            <pubDate>Tue, 29 Sep 2009 13:00:33 +0100</pubDate>
            <guid isPermaLink="false">2842729</guid>        </item>
        <item>
            <title>SNEAK PREVIEW: “Epic” New Book, Diabetes Rising</title>
            <link>http://www.medworm.com/index.php?rid=2828413&amp;cid=t_117220_134_f&amp;fid=34841&amp;url=http%3A%2F%2Fwww.diabetesmine.com%2F2009%2F09%2Fsneak-preview-epic-new-book-diabetes-rising.html</link>
            <description>Curious about what&amp;#8217;s happening in the diabetes industry and research community? Or maybe (like me) you think that you already know what&amp;#8217;s going on&amp;#8230; Well, get ready for a concise and extremely entertaining exposé of the current status of diabetes care and research towards a cure.
The title is Diabetes Rising, the new &amp;#8220;epic [...] (Source: Diabetes Mine)</description>
            <author>Diabetes Mine</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2828413</comments>
            <pubDate>Thu, 24 Sep 2009 14:55:27 +0100</pubDate>
            <guid isPermaLink="false">2828413</guid>        </item>
        <item>
            <title>The Situational Consequences of Uncertainty</title>
            <link>http://www.medworm.com/index.php?rid=2828272&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2009%2F09%2F24%2Fthe-situational-consequences-of-uncertainty%2F</link>
            <description>This spring, Situationist friend, Dan Gilbert published another illuminating and entertaining op-ed, titled &amp;#8220;What We Don’t Know Makes Us Nervous,&amp;#8221; (New York Times, May 21, 2009).  Here&amp;#8217;s an excerpt.

* * *
Seventy-six years ago, Franklin Delano Roosevelt took to the inaugural dais and reminded a nation that its recent troubles “concern, thank God, only material things.” In the midst of the Depression, he urged Americans to remember that “happiness lies not in the mere possession of money” and to recognize “the falsity of material wealth as the standard of success.” 
“The only thing we have to fear,” he claimed, “is fear itself.” 
As it turned out, Americans had a great deal more to fear than that, and their innocent belief that money buys happiness ...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2828272</comments>
            <pubDate>Thu, 24 Sep 2009 04:01:51 +0100</pubDate>
            <guid isPermaLink="false">2828272</guid>        </item>
        <item>
            <title>Dan Wegner Visits Harvard Law</title>
            <link>http://www.medworm.com/index.php?rid=2772571&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2009%2F09%2F07%2Fdan-wegner-visits-harvard-law%2F</link>
            <description>On Tuesday, September 8, the HLS Student Association for Law and Mind Sciences (SALMS) is hosting a talk by Professor Daniel Wegner on “Psychological Studies of the Guilty Mind.”  The event will take place in Pound 108 at Harvard Law School, from 12:00 &amp;#8211; 1:00 p.m. (and lunch will be served &amp;#8211; first come, first served).
SALMS is a student organization working in conjunction with the Project on Law and Mind Sciences to bring to legal academia (in this case, specifically, the Harvard Law School community) the ground-breaking mind sciences research that has profound implications for law and legal theory.  SALMS has a very exciting schedule of events planned for the fall semester.  Additional upcoming speakers include Fiery Cushman, Andrew Papachristos, Goutam Jois, Mahzarin ...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2772571</comments>
            <pubDate>Mon, 07 Sep 2009 04:01:19 +0100</pubDate>
            <guid isPermaLink="false">2772571</guid>        </item>
        <item>
            <title>Dan Ariely on the Situation of Expectation</title>
            <link>http://www.medworm.com/index.php?rid=2727164&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2009%2F08%2F24%2Fis-there-an-objective-reality-outside-of-our-beliefs-%25e2%2580%2594-big-think%2F</link>
            <description>The good folks at Big Think interviewed behavioral economist Dan Ariely and asked him about the the nature of objective reality. Among other things, Ariely had this to say:
It turns out that if a physician comes to you and injects you with whatever – saline water – your body expects pain relief.  And your body secretes substances that are very much like morphine.  So it doesn’t matter what you get from the injection.  You actually get pain relief from your own body as a reaction to that.  Now you can’t just close your eyes and say, “Please can I have some pain killers.”  That doesn’t work.  But when a physician injects you with anything – even saline water – you get the pain relief that is actually a substance you can’t buy over the counter.  It’s like morphine...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2727164</comments>
            <pubDate>Mon, 24 Aug 2009 04:01:08 +0100</pubDate>
            <guid isPermaLink="false">2727164</guid>        </item>
        <item>
            <title>Dan Gilbert on the Situation of Psychology</title>
            <link>http://www.medworm.com/index.php?rid=2716003&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2009%2F08%2F20%2Fdan-gilbert-on-the-situation-of-psychology%2F</link>
            <description>The good folks at Big Think interviewed Situationist friend Dan Gilbert and asked him about the future of psychology.  Among other things, Gilbert had this to say.
Surely the other big problem facing psychology is the problem facing any behavioral science in the United States of America, which is we have leaders who don’t much appreciate behavioral science. It’s an odd thing, given that virtually every problem you’re trying to solve is a problem of human behavior. These aren’t sciences that gather much respect. And as a result, they’re not sciences that are doing very well in terms of funding. It’s quite possible that psychology as we know it won’t exist as a science in 10 or 15 years if we follow the present course of funding in the U.S.A.
The video of his complete response...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2716003</comments>
            <pubDate>Thu, 20 Aug 2009 04:02:02 +0100</pubDate>
            <guid isPermaLink="false">2716003</guid>        </item>
        <item>
            <title>The Situation of Pain</title>
            <link>http://www.medworm.com/index.php?rid=2594464&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2009%2F07%2F13%2Fthe-situation-of-pain%2F</link>
            <description>This study shows that even if two harmful events are physically identical, the one delivered with the intention to hurt actually hurts more,&amp;#8221; says Gray. &amp;#8220;Compare a slap from a friend as she tries to save us from a mosquito versus the same slap from a jilted lover. The first we shrug off instantly, while the second stings our cheek for the rest of the night.&amp;#8221;
The study&amp;#8217;s authors suggest that intended and unintended harm cause different amounts of pain because they differ in meaning.
&amp;#8220;From decoding language to understanding gestures, the mind distills meaning from our social environment,&amp;#8221; says Gray. &amp;#8220;An intended harm has a very different meaning than an accidental harm.&amp;#8221;
The study included 48 participants who were paired up with a partner who c...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2594464</comments>
            <pubDate>Mon, 13 Jul 2009 04:01:07 +0100</pubDate>
            <guid isPermaLink="false">2594464</guid>        </item>
        <item>
            <title>Good legal advice for Genomics.....</title>
            <link>http://www.medworm.com/index.php?rid=2591636&amp;cid=t_117220_131_f&amp;fid=35743&amp;url=http%3A%2F%2Fthegenesherpa.blogspot.com%2F2009%2F07%2Fgood-legal-advice-for-genomics.html</link>
            <description>I have often thought that the laws which currently govern genomics, medicine and direct to consumer products are prettty interesting.Which is why, when we started our medical practices we were going to do an internet distribution of testing and consultation........ This was back in 2005. We sat late up at night in my partners apartment plotting to take over the industry.We aligned some players and then we obtained some legal advice....... After that fateful day in 2005, we realized that this was a buzzsaw we did not want to mess with......Especially in New York, Our Market! So you can imagine my incredulity when we saw 3 companies planning to do precisely what we were advised legally not to do. The mistakes these companies made were exactly the issues we were advised to avoid. We spent a m...</description>
            <author>Gene Sherpas: Personalized Medicine and You</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2591636</comments>
            <pubDate>Fri, 10 Jul 2009 12:52:00 +0100</pubDate>
            <guid isPermaLink="false">2591636</guid>        </item>
        <item>
            <title>Dan Ariely, a Situationist</title>
            <link>http://www.medworm.com/index.php?rid=2452657&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2009%2F06%2F05%2Fdan-ariely-as-a-situationist%2F</link>
            <description>In the following TED Talk video, Dan Ariely, Professor of Economics at Duke University, behavioral economist, and the author of Predictably Irrational, offers some now-standard but still interesting illustrations of how situation influences our perception and choices.
* * *


* * *
To read (or watch) some related Situationist posts, see &amp;#8220;Dan Ariely on Cheating,&amp;#8221; &amp;#8220;Free To Not Choose,&amp;#8221; “Why You Bought That,” “Just Choose It,” &amp;#8220;Neuroscience and Illusion,&amp;#8221; “Brain Magic,” “Magic is in the Mind,” and “The Situation of Illusion,” &amp;#8220;Irrelevant Third Options in Presidential Campaigns.” (Source: The Situationist)</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2452657</comments>
            <pubDate>Fri, 05 Jun 2009 04:01:57 +0100</pubDate>
            <guid isPermaLink="false">2452657</guid>        </item>
        <item>
            <title>The power of Twitter and why blogging matters.</title>
            <link>http://www.medworm.com/index.php?rid=2452970&amp;cid=t_117220_131_f&amp;fid=35743&amp;url=http%3A%2F%2Fthegenesherpa.blogspot.com%2F2009%2F06%2Fpower-of-twitter-and-why-blogging.html</link>
            <description>I am certain there must be a million stories like this out there. Devoted Twitterer attends conference that others cannot, recaps the talks via twitter as physician/new papa/blogger/entrepreneur virtually attends the conference via twitter and can give color commentary...... Or this one: Conference presenters hamstring regular news, while blogger gets strategic advantage by not registering as a journalist. Thus scooping the press...... Well, I have now seen and appreciated both in real time.This weekend while I was recovering and taking care of our newborn I was able to attend a conference the AAAS hosted a conference entitled  &quot;Personalized Medicine, Planning for the Future&quot; it was a scientific freedom, responsibility and the law program......... The microblogger was Dan Vorhaus Esquire a...</description>
            <author>Gene Sherpas: Personalized Medicine and You</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2452970</comments>
            <pubDate>Thu, 04 Jun 2009 12:01:00 +0100</pubDate>
            <guid isPermaLink="false">2452970</guid>        </item>
        <item>
            <title>The Situation of Climate Change</title>
            <link>http://www.medworm.com/index.php?rid=2376171&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2009%2F04%2F29%2Fthe-situation-of-climate-change%2F</link>
            <description>From Pop!Tech and YouTube, here is Situationist friend, Harvard Professor Daniel Gilbert speaking  about the psychology of global warming.
* * *



* * *
For related Sitautionist posts, see &amp;#8220;Jeffrey Sachs on the Situation of Global Poverty,&amp;#8221; &amp;#8220;The Need for a Situationist Morality,&amp;#8221; &amp;#8220;The Heat is On,&amp;#8221; and &amp;#8220;Captured Science.&amp;#8221; (Source: The Situationist)</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2376171</comments>
            <pubDate>Wed, 29 Apr 2009 05:11:53 +0100</pubDate>
            <guid isPermaLink="false">2376171</guid>        </item>
        <item>
            <title>Achieving impossible heights</title>
            <link>http://www.medworm.com/index.php?rid=2364999&amp;cid=t_117220_88_f&amp;fid=38129&amp;url=http%3A%2F%2Fsandnsurf.medbrains.net%2F2009%2F04%2Fachieving-impossible-heights-2%2F</link>
            <description>With Peter Habeler, Reinhold Messner made the first oxygenless ascent of Everest in 1978. Messner later became the first man to climb all fourteen of the world&amp;#8217;s giant 8000-meter peaks. In 1980 he climbed Everest solo - without oxygen - in a blitzkrieg expedition lasting only three days. Messner&amp;#8217;s ground-breaking climbing feats exceeded many people&amp;#8217;s [...] (Source: Life in the Fast Lane)</description>
            <author>Life in the Fast Lane</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2364999</comments>
            <pubDate>Fri, 24 Apr 2009 21:00:23 +0100</pubDate>
            <guid isPermaLink="false">2364999</guid>        </item>
        <item>
            <title>Metastatic liver cancer prognosis</title>
            <link>http://www.medworm.com/index.php?rid=2163664&amp;cid=t_117220_136_f&amp;fid=35300&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmetastatic-liver-cancer%2F%7E3%2F3EO7hFRIAXw%2F</link>
            <description>Read why any conventional liver cancer prognosis by itself reduces your chances of survival by 80%. This is because a conventional prognosis is based on &amp;quot;normal medical efforts to treat secondary liver cancer&amp;quot;.
&amp;nbsp;
Learn how our metastatic liver cancer survivors step outside the box.
&amp;nbsp;
Conventional cancer prognosis is only 1 part of the puzzle of your health
&amp;nbsp;
In stead of asking for a metastatic liver cancer prognosis, you need to ask: 
&amp;nbsp;
‘Maybe there’s a chance’?

&amp;nbsp;
This will challenge your doctor. 
&amp;nbsp;
Not that your doctor suddenly will perform a miracle. But it&amp;#8217;s a much better way to start a dialogue with yourself and the caregivers around you.
&amp;nbsp;
Our father&amp;#8217;s metastatic liver cancer prognosis
&amp;nbsp;
When we asked several doctors...</description>
            <author>Metastatic liver cancer</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2163664</comments>
            <pubDate>Fri, 06 Feb 2009 07:11:28 +0100</pubDate>
            <guid isPermaLink="false">2163664</guid>        </item>
        <item>
            <title>Making the Switch to Web-based Medical Practice Management</title>
            <link>http://www.medworm.com/index.php?rid=2128795&amp;cid=t_117220_113_f&amp;fid=34634&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FEmrAndHipaa%2F%7E3%2FOt_EUZZ3Bvs%2F</link>
            <description>I recently invited the President and Owner of Great Acclaim LLC to do a guest post for this blog talking about the benefits of switching to a web based medical practice management. The hope was to illustrate the increased reimbursement that can be achieved by using a well managed practice management software (or SAAS - Software as a Service).
This blog has focused a lot on EMR and EHR, but hasn&amp;#8217;t focused enough on the benefits of an electronic practice management service. The following guest post from Dan Williams will hopefully shed some more light on the benefits of a web based medical practice management implementation.
Guest Post by Dan Williams
Physicians face an array of options linked with the decision to switch to Web-based practice management solutions. Like EMR implementati...</description>
            <author>EMR and HIPAA</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2128795</comments>
            <pubDate>Fri, 23 Jan 2009 08:01:55 +0100</pubDate>
            <guid isPermaLink="false">2128795</guid>        </item>
        <item>
            <title>More Thoughts on Recovery, Again While Grocery Shopping</title>
            <link>http://www.medworm.com/index.php?rid=2046915&amp;cid=t_117220_133_f&amp;fid=35096&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAutismVox%2F%7E3%2FDN0Djg95KF0%2F</link>
            <description>So yesterday I wrote &amp;#8220;what comes around, comes around.&amp;#8221; Siliconmom commented about this sentence, the last one in the post:
Is that one of the stages of being an autistic parent - that at some point you realize and accept that life is what it is?
For me, I would say, yes, very much, and that, too, hope starts with acceptance.
Charlie was around 5 years old when I let go of feeling I had to save him from, and fight against, and do the warrior mom thing. I&amp;#8217;m not saying I don&amp;#8217;t have moments when a shadow of the old &amp;#8220;fightin&amp;#8217; spirit&amp;#8221; passes through me (pre-IEP meeting, for instance, or when you get The Stare-&amp;#8217;n'-Shakes-Head Combo in the supermarket). Being Charlie&amp;#8217;s mom is not about doing everything I can to &amp;#8220;take the autism out of hi...</description>
            <author>Autism Vox</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2046915</comments>
            <pubDate>Thu, 18 Dec 2008 06:36:35 +0100</pubDate>
            <guid isPermaLink="false">2046915</guid>        </item>
        <item>
            <title>The Situation of Food - Part VI</title>
            <link>http://www.medworm.com/index.php?rid=2040525&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2008%2F12%2F17%2Fforatv-whats-for-dinner-food-politics-in-21st-century%2F</link>
            <description>From FORA.tv: Author Michael Ruhlman and Chef Dan Barber talk about modern industrial farming and agriculture in the United States as part of Chautauqua Institutions week long program called &amp;#8220;What&amp;#8217;s for Dinner: Food and Politics in the 21st Century.&amp;#8221;

* * *
For related Situationist posts, go to “The Situation of our Food – Part I,” “The Situation of Our Food - Part II,” “The Situation of Our Food - Part III,” and &amp;#8220;The Situation of our Food - Part IV.&amp;#8221;

&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (Source: The Situationist)</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2040525</comments>
            <pubDate>Wed, 17 Dec 2008 04:01:12 +0100</pubDate>
            <guid isPermaLink="false">2040525</guid>        </item>
        <item>
            <title>Achieving impossible heights…</title>
            <link>http://www.medworm.com/index.php?rid=2036317&amp;cid=t_117220_88_f&amp;fid=38203&amp;url=http%3A%2F%2Fprecordialthump.medbrains.net%2F2008%2F12%2F15%2Fachieving-impossible-heights%2F</link>
            <description>With Peter Habeler, Reinhold Messner made the first oxygenless ascent of Everest in 1978. Messner later became the first man to climb all fourteen of the world&amp;#8217;s giant 8000-meter peaks. In 1980 he climbed Everest solo - without oxygen - in a blitzkrieg expedition lasting only three days. Messner&amp;#8217;s ground-breaking climbing feats exceeded many people&amp;#8217;s conceptions of the limits of what human physiology and the human spirit are capable of.
So, what are the unique qualities that allow elite alpinists to achieve these superhuman feats?
Dr O. Oelz, himself an Everest summiter, and his colleagues studied the physiology of six elite climbers, including Messner and Habeler, to try to answer this question in their 1986 paper:
Oelz O, Howald H, Di Prampero PE, Hoppeler H, Claassen H...</description>
            <author>AEQUANIMITAS</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2036317</comments>
            <pubDate>Mon, 15 Dec 2008 13:03:31 +0100</pubDate>
            <guid isPermaLink="false">2036317</guid>        </item>
        <item>
            <title>How to survive secondary liver cancer</title>
            <link>http://www.medworm.com/index.php?rid=2035879&amp;cid=t_117220_136_f&amp;fid=35300&amp;url=http%3A%2F%2Fwww.metastaticlivercancer.org%2F2008-12-15-cancer-treatment%2Fsecondary-liver-cancer-2%2F</link>
            <description>Conclusion
&amp;nbsp;
Modern health care is great when you fall and your arm is broken, they can fix it back quite well.
&amp;nbsp;
Modern health care falls short when it comes to preventing and treating cancer.
&amp;nbsp;
To survive secondary canceryou need to do everything right!
&amp;nbsp;
Mind and matter
&amp;nbsp;
Jim summarizes it all: 
&amp;nbsp;
I have to admit that I think the complimentary cancer treatment is helping with the chemotherapy. 
&amp;nbsp;
I don’t know but something seems to be working.

&amp;nbsp;
I would say, in order to survive secondary liver cancer you need to:
&amp;nbsp;


use modern medicine to your benefit: if a chemotherapy works, then undergo the treatment&amp;nbsp;
believe you are going to live it through&amp;nbsp;
use ALL the extra help you can get

&amp;nbsp;
A strong body with the right mind-set or ...</description>
            <author>Metastatic liver cancer</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2035879</comments>
            <pubDate>Mon, 15 Dec 2008 06:01:28 +0100</pubDate>
            <guid isPermaLink="false">2035879</guid>        </item>
        <item>
            <title>Novartis’ Vasella: This Is A Very Rewarding Job</title>
            <link>http://www.medworm.com/index.php?rid=2021732&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F478384168%2F</link>
            <description>Coy as ever, Dan Vasella plays down speculation that he is inching closer to moving on. Asked yet again, about his recent decision to appoint former vaccines head Joerg Reinhardt a new chief operating officer, the Novartis ceo says that, after 12 years on the job, he still gets a thrill.
&amp;#8220;I don&amp;#8217;t know if baby is the right word, but there is an emotional connection and a deep desire that (Novartis) succeeds and that it&amp;#8217;s going well and that people are happy, at least most of the time,&amp;#8221; he tells Reuters. &amp;#8220;I see many reasons to go but I see even more reasons to continue.&amp;#8221;
&amp;#8220;The obvious is sometimes not what happens. I believe that some people probably believe that, others probably don&amp;#8217;t believe it. I explicitly said that it would be, in my view, ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2021732</comments>
            <pubDate>Mon, 08 Dec 2008 11:48:08 +0100</pubDate>
            <guid isPermaLink="false">2021732</guid>        </item>
        <item>
            <title>Liver cancer or metastatic liver cancer?</title>
            <link>http://www.medworm.com/index.php?rid=1990932&amp;cid=t_117220_136_f&amp;fid=35300&amp;url=http%3A%2F%2Fwww.metastaticlivercancer.org%2F2008-11-27-cancer-treatment%2Fliver-cancer-or-metastatic-liver-cancer%2F</link>
            <description>Whitney&amp;#8217;s father is diagnosed with liver cancer stage 4 and asks our metastatic liver cancer survivors for advice. Eating more small portions a day is a smart practical solution to deal with an expanding liver.
&amp;nbsp;
What does liver cancer stage 4 mean exactly?
&amp;nbsp;
You have to ask your doctor to explain that sentence, as it can be quite confusing but utterly important for the treatment of the cancer: 
&amp;nbsp;

Stage iv colon cancer means you have cancer that started in the colon that has metastasized or moved to other organs like most commonly the liver.&amp;nbsp;
Stage iv breast cancer means you have cancer that started in the colon that has metastasized or moved to other organs like most commonly bones, liver, or lung.&amp;nbsp;
Stage iv liver cancer means you have cancer that started i...</description>
            <author>Metastatic liver cancer</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1990932</comments>
            <pubDate>Thu, 27 Nov 2008 07:24:52 +0100</pubDate>
            <guid isPermaLink="false">1990932</guid>        </item>
        <item>
            <title>Dan Kahneman’s Situation</title>
            <link>http://www.medworm.com/index.php?rid=1945597&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2008%2F11%2F09%2Fdan-kahnemans-situation%2F</link>
            <description>In the following video, Harry Kreisler interviews Princeton Psychology Professor and Nobel Laureate Daniel Kahneman about his life as well as his research on intuition and decision making.


&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; (Source: The Situationist)</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1945597</comments>
            <pubDate>Sun, 09 Nov 2008 05:08:56 +0100</pubDate>
            <guid isPermaLink="false">1945597</guid>        </item>
        <item>
            <title>Novartis Tries To Makeover Its Image In India</title>
            <link>http://www.medworm.com/index.php?rid=1924713&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F436874506%2F</link>
            <description>Dan Vasella may have used harsh words last year when he lost a patent battle in India, but the country holds so much potential, it appears the Novartis ceo is now trying to find a way to make nice. And so the drugmaker is sponsoring a camp to groom young biotech talent in the country. 
Last year, you may recall, Dan vowed to switch hundreds of millions of dollars in planned investments from India to other locations, such as China, in response to an Indian court ruling over a patent for the Gleevec cancer drug, which he argued would weaken intellectual property rights on new meds (back story).
&amp;#8220;This (ruling) is not an invitation to invest in Indian research and development, which we would have done,&amp;#8221; he said at the time. &amp;#8220;We will invest more in countries where we have prot...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1924713</comments>
            <pubDate>Thu, 30 Oct 2008 12:30:43 +0100</pubDate>
            <guid isPermaLink="false">1924713</guid>        </item>
        <item>
            <title>DAN! Releases Video Documentry</title>
            <link>http://www.medworm.com/index.php?rid=1902633&amp;cid=t_117220_133_f&amp;fid=37107&amp;url=http%3A%2F%2Fwww.aspieweb.net%2Fdan-releases-video-documentry%2F</link>
            <description>Dr. Doreen Granpeesheh and Defeat Autism Now have created a new video documentry which is planned to be revealed as part of the national Defeat Autism Now (DAN!) national conference in San Diego, CA.  The film tells the story of four children diagnosed with autism, who achieved success using treatments rooted in Applied Behavior Analysis. [...] (Source: AspieWeb.net)</description>
            <author>AspieWeb.net</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1902633</comments>
            <pubDate>Thu, 23 Oct 2008 13:34:52 +0100</pubDate>
            <guid isPermaLink="false">1902633</guid>        </item>
        <item>
            <title>How to survive metastatic liver cancer?</title>
            <link>http://www.medworm.com/index.php?rid=1901663&amp;cid=t_117220_136_f&amp;fid=35300&amp;url=http%3A%2F%2Fwww.metastaticlivercancer.org%2F2008-10-23-cancer-treatment%2Fhow-to-survive-metastatic-liver-cancer%2F</link>
            <description>Trish, one of our 2 metastatic liver cancer survivors has some questions for Dan - our other metastatic liver cancer survivor-. 
&amp;nbsp;
Trish: recommended readings about cancer and cancer stages: 
&amp;nbsp;

colon cancer stages: an overview from Stage 0 cancer to Stage IV cancer&amp;nbsp;
Stages of throat cancer: a clear overview of 2 different ways of identifying or &amp;quot;staging&amp;quot; a cancer with clear huge pictures of throat cancer stages&amp;nbsp;

colon cancer staging: why staging is important: the size of your tumor doesn&amp;#8217;t show the whole disease (father had an unknown primary cancer, meaning the size of his primary tumor was so small it couldn&amp;#8217;t be detected).&amp;nbsp; &amp;nbsp;
liver cancer survival rate&amp;nbsp;
Stage 4 liver cancer

&amp;nbsp;
I have the following questions for both Dan and...</description>
            <author>Metastatic liver cancer</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901663</comments>
            <pubDate>Thu, 23 Oct 2008 05:37:56 +0100</pubDate>
            <guid isPermaLink="false">1901663</guid>        </item>
        <item>
            <title>The Market’s Personality: Dispositionalizing Situational Characters</title>
            <link>http://www.medworm.com/index.php?rid=1798602&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2008%2F09%2F17%2Fthe-markets-personality-dispositionalizing-situational-characters%2F</link>
            <description>Joel Garreau and Shankar Vedantam have a nice article, &amp;#8220;Dealing with Scary Mr. Market,&amp;#8221; in Tuesday&amp;#8217;s Washington Post about the human tendency to see human tendencies in non-humans.  The inclination to anthropomorphize is, in our view, better understood as another example of the inclination to dispositionalize &amp;#8212; a misleading bias even when directed at the human animal. 
Here are some excerpts from the article.
* * *
A rough beast prowled yesterday. If you read the business press, the market woke up with &amp;#8220;jitters&amp;#8221; after playing &amp;#8220;a game of chicken.&amp;#8221; It wound up suffering from &amp;#8220;dizziness,&amp;#8221; recoiling from a &amp;#8220;campfire&amp;#8221; possibly turning into a &amp;#8220;forest fire,&amp;#8221; or a destructive &amp;#8220;tsunami.&amp;#8221;
Really?
The mar...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1798602</comments>
            <pubDate>Wed, 17 Sep 2008 04:01:23 +0100</pubDate>
            <guid isPermaLink="false">1798602</guid>        </item>
        <item>
            <title>Vasella On Roche: We Are Consistent, Almost Boring</title>
            <link>http://www.medworm.com/index.php?rid=1798528&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F393141632%2F</link>
            <description>But only when it comes to Roche. Novartis, you may recall, has a 33 percent stake in its Swiss rival and Dan Vasella is always being asked when will he move to acquire more. In an intervie with Germany&amp;#8217;s Handelsblatt, however, he says there are no plans to takeover Roche.
In fact, Dan says he does not plan any more big acquisitions after digesting a big stake in Alcon, the eye-care company. That &amp;#8220;settled the question of further big acquitions,&amp;#8221; he told the paper, according to Reuters. &amp;#8220;That is not up for debate at the moment and so it is a purely hypothetical question.&amp;#8221;
But what about the idea of selling the Roche stake to pay for the Alcon deal? &amp;#8220;We are very consistent, almost boring as far as our involvement in Roche is concerned.&amp;#8221; (Source: Pharm...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1798528</comments>
            <pubDate>Mon, 15 Sep 2008 11:54:32 +0100</pubDate>
            <guid isPermaLink="false">1798528</guid>        </item>
        <item>
            <title>Denial</title>
            <link>http://www.medworm.com/index.php?rid=1701537&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2008%2F08%2F12%2Fdenial%2F</link>
            <description>Last November, Benedict Carey of the New York Times penned an intriguing piece on the psychology of denial. As discussed by Carey, recent research suggests that denial helps form and cultivate close relationships, including those between spouses and siblings. We excerpt his piece below.
* * *
Everyone is in denial about something; just try denying it and watch friends make a list. For Freud, denial was a defense against external realities that threaten the ego, and many psychologists today would argue that it can be a protective defense in the face of unbearable news, like a cancer diagnosis.
* * *
[R]ecent studies from fields as diverse as psychology and anthropology suggest that the ability to look the other way, while potentially destructive, is also critically important to forming and ...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1701537</comments>
            <pubDate>Wed, 13 Aug 2008 06:16:32 +0100</pubDate>
            <guid isPermaLink="false">1701537</guid>        </item>
        <item>
            <title>OOH! Narrowcast DTC Advertising</title>
            <link>http://www.medworm.com/index.php?rid=1671518&amp;cid=t_117220_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F07%2Fooh-dtc-advertising.html</link>
            <description>According to a Wikipedia entry, &quot;Out-of-home advertising (also referred to as OOH) is essentially any type of advertising that reaches the consumer while he or she is outside the home. This is in contrast to broadcast, print, or internet advertising...&quot; The most familiar form of OOH advertising in the U.S. is billboards.According to AdvertisingAge, the Top 200 U.S. non-pharmaceutical company advertisers allocated 1.9% of their measured ad dollars to OOH ads, whereas the Top 13 pharma advertisers allocated only 0.1% of their ad budgets to OOH.OOH is another channel aside from the Internet that pharma marketers are ignoring!Why is that?Well, OOH is even worse than the Internet in terms of reaching masses of people with the same ad and proving that the return is worth the effort. Billboards, ...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1671518</comments>
            <pubDate>Thu, 31 Jul 2008 16:10:00 +0100</pubDate>
            <guid isPermaLink="false">1671518</guid>        </item>
        <item>
            <title>Glaxo Hires Former FDA Chief Counsel Dan Troy</title>
            <link>http://www.medworm.com/index.php?rid=1646370&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F342873843%2F</link>
            <description>The preemption prince is joining the big drugmaker as senior vice president and general counsel on September 2. This is a coup for Glaxo, because Troy is widely known - some might say notorious - for being supportive of the pharmaceutical industry (see here).
During his tenure as FDA chief counsel, Troy instructed agency staff to issue fewer warning letters in the belief that the missives were being ignored, which critics say led to less effective enforcement of advertising violations. He also laid the groundwork for the current legal battle over preemption, which says FDA approval supercedes state law claims challenging safety, efficacy, or labeling. Drugmakers and the FDA argue preemption exists by maintaining agency actions are the final word on safety and effectiveness.
A case goes bef...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1646370</comments>
            <pubDate>Tue, 22 Jul 2008 20:19:24 +0100</pubDate>
            <guid isPermaLink="false">1646370</guid>        </item>
        <item>
            <title>Bill Clinton Hopes To Cut Prices On Malaria Drugs</title>
            <link>http://www.medworm.com/index.php?rid=1635183&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F338154644%2F</link>
            <description>Former President Bill Clinton&amp;#8217;s foundation is set to unveil a pricing agreement that it hopes will make malaria drugs available to millions of poor people, The Wall Street Journal reports. 
A key problem has been that the key ingredient in first-line malaria drugs - artemisinin-based combination therapies, or ACTs - has fluctuated greatly in price. the antimalarial plant extract artemisinin has cost anywhere from $150 a kilogram to $1,100, the paper writes.
Such instability makes planning difficult for artemisinin producers and health ministries that often buy the drugs. Drugmakers say reducing prices is difficult if another price spike occurs. And generic drugmakers may be deterred from entering the market and fostering more-competitive pricing.
Clinton plans to announce aims to lim...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1635183</comments>
            <pubDate>Thu, 17 Jul 2008 15:31:53 +0100</pubDate>
            <guid isPermaLink="false">1635183</guid>        </item>
        <item>
            <title>Free To Not Choose</title>
            <link>http://www.medworm.com/index.php?rid=1616618&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2008%2F07%2F12%2Ffreedom-to-not-choose%2F</link>
            <description>In February, John Tierney wrote a great column in February for the New York Times about Dan Ariely&amp;#8217;s new book, Predictably Irrational.  We already posted about Ariely&amp;#8217;s book last week (see here).  In this post, we simply wanted to highlight Tierney&amp;#8217;s excellent summary of some of Ariely&amp;#8217;s experiments.
* * *
In a series of experiments, hundreds of students could not bear to let their options vanish . . . .
* * *
They played a computer game that paid real cash to look for money behind three doors on the screen. . . . After they opened a door by clicking on it, each subsequent click earned a little money, with the sum varying each time.
As each player went through the 100 allotted clicks, he could switch rooms to search for higher payoffs, but each switch used up a clic...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1616618</comments>
            <pubDate>Sat, 12 Jul 2008 20:00:32 +0100</pubDate>
            <guid isPermaLink="false">1616618</guid>        </item>
        <item>
            <title>Predictably Irrational</title>
            <link>http://www.medworm.com/index.php?rid=1606315&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.files.wordpress.com%2F2008%2F04%2Fabc-dan-ariely-interview.mp3</link>
            <description>We presented participants with two portraits – Mike and John – and asked them to choose whom they&amp;#8217;d rather date. For half the participants we distorted the picture of Mike and added it to the set, so they had John, Mike and an ugly version of Mike to choose from. For the other half of the students, we distorted John, so they had Mike, John and an ugly John.
When the ugly version of Mike was presented, the attractive version of Mike became the most desirable date. And when the ugly version of John was presented, John&amp;#8217;s attractive version became the most desirable.
It is very hard for us to evaluate things in absolute terms. So, we evaluate products and people in relative terms, which makes us vulnerable to this kind of trap, called the asymmetric dominance effect.
Spending p...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1606315</comments>
            <pubDate>Fri, 11 Jul 2008 03:07:00 +0100</pubDate>
            <guid isPermaLink="false">1606315</guid>        </item>
        <item>
            <title>Banned In Boston? Two Docs Debate The Gift Ban</title>
            <link>http://www.medworm.com/index.php?rid=1502742&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F307986757%2F</link>
            <description>As Massachusetts contemplates telling pharma that gifts to docs should be a no-no, a Boston TV station invites Danny Carlat, a psychiatrist and medical gadfly, and Tom Stossel, of Brigham and Women&amp;#8217;s Hospital, to debate the ins and outs. 
Stossel, who wrote critcized the proposed legislation in a recent editorial in The Boston Herald, calls the idea &amp;#8216;draconian,&amp;#8217; and says &amp;#8216;if I never see another Pfizer mug, I&amp;#8217;m not going to worry about it.&amp;#8217; Carlat, meanwhile, says that &amp;#8216;gifts is another word for bribes.&amp;#8217; (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1502742</comments>
            <pubDate>Mon, 09 Jun 2008 12:27:17 +0100</pubDate>
            <guid isPermaLink="false">1502742</guid>        </item>
        <item>
            <title>Novartis CEO Issues Warning To Switzerland</title>
            <link>http://www.medworm.com/index.php?rid=1472701&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F299010451%2F</link>
            <description>Dan Vasella isn&amp;#8217;t pleased that Swiss Interior Minister Pascal Couchepin would like to see lower drug prices. So in comments to the Berner Zeitung newspaper over the weekend, Dan reminds the Couchepin that lower drug prices would be &amp;#8220;a double-edged sword&amp;#8221; that could have a negative effect on Switzerland, SwissInfo reports.
&amp;#8220;The pressure from (Couchepin) is too strong,&amp;#8221; he told the newspaper. &amp;#8220;Drugs in Switzerland are now cheaper than in Germany.&amp;#8221; How so? Dan argued that reduced prices could decrease the amount companies invest in research and development, and added that new drugs reduced overall hospital costs.
And let&amp;#8217;s not forget, Dan added, that lower prices would affect tax revenues. Novartis pays roughly $488 million in tax to the Swiss g...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1472701</comments>
            <pubDate>Tue, 27 May 2008 10:50:24 +0100</pubDate>
            <guid isPermaLink="false">1472701</guid>        </item>
        <item>
            <title>Law, Chicken Sexing, Torture Memo, and Situation Sense</title>
            <link>http://www.medworm.com/index.php?rid=1467964&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2008%2F05%2F25%2Flaw-chicken-sexing-torture-memo-and-situation-sense%2F</link>
            <description>It&amp;#8217;s law-school graduation season. Here is one of the best law-school commencement speeches in recent memory, given by Situationist contributor Dan Kahan at Yale Law School two years ago.
* * *
I’m sure we are all moved by the profound and unique signification of commencement exercises at Yale Law School. At other, lesser law schools, commencement marks the successful completion of a program in legal education. But at Yale, commencement means just that – a start, a beginning.
Having earned your Juris Doctorate from Yale, the time has come for you finally to commence learning real law. Well, today I’d like to offer you an apology for the distinctive brand of legal education you received here. Of course I mean apology not as in a contrite acknowledgment of fault, but apology as i...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1467964</comments>
            <pubDate>Mon, 26 May 2008 02:57:44 +0100</pubDate>
            <guid isPermaLink="false">1467964</guid>        </item>
        <item>
            <title>Who’s Delusional? A University Doc &amp; A Clinical Trial</title>
            <link>http://www.medworm.com/index.php?rid=1451977&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F293418021%2F</link>
            <description>Dan Markingson, known as Subject 13 in a clinical trial at the University of Minnesota, killed himself four years ago. A university official described his death as &amp;#8220;tragic&amp;#8221; and a &amp;#8220;serious adverise event&amp;#8221; in a memo to the FDA, while noting that suicide was, &amp;#8220;unfortunately, not uncommon in this study population.&amp;#8221; But not unpredictable, The St. Paul Pioneer-Press writes.
His mother later filed a lawsuit, accusing Markingson&amp;#8217;s psychiatrist and the study&amp;#8217;s director, Stephen Olson, of coercing him to sign up. The lawsuit also claimed the university kept Markingson enrolled to preserve its research and to keep payments coming for his participation, according to the paper. The study, which was funded by AstraZeneca and spread among 26 institutions, c...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1451977</comments>
            <pubDate>Mon, 19 May 2008 10:52:45 +0100</pubDate>
            <guid isPermaLink="false">1451977</guid>        </item>
        <item>
            <title>FDA Chief Counsel Undercut Changes In Procrit Ad</title>
            <link>http://www.medworm.com/index.php?rid=1437089&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F288911894%2F</link>
            <description>The FDA made a series of unsuccessful attempts to stop a direct-to-consumer advertising campaign that claimed that Johnson &amp;#038; Johnson’s Proctit improved “fatigue” associated with chemotherapy-induced anemia, The Cancer Letter reports.
The ads, which were widely credited with making ESA drugs into the biggest-selling class of oncology drugs, were allowed to proceed with relatively minor changes after the FDA Office of Chief Counsel got involved in the controversy. 
The details of the doomed effort by FDA staff to modify the Procrit campaign emerged in documents that were placed in the public record at the May 8 hearing of the House Committee on Energy and Commerce&amp;#8217;s Subcommittee on Oversight and Investigation. (Look here).
A sequence of internal FDA emails released by the co...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1437089</comments>
            <pubDate>Mon, 12 May 2008 19:50:11 +0100</pubDate>
            <guid isPermaLink="false">1437089</guid>        </item>
        <item>
            <title>Ayn Rand’s Dispositionism: The Situation of Ideas</title>
            <link>http://www.medworm.com/index.php?rid=1433968&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2008%2F05%2F10%2Fian-rand-and-the-situation-of-ideas%2F</link>
            <description>Last week Clark Davis had a piece titled &amp;#8220;Ayn Rand Studies on Campus,&amp;#8221; on NPR&amp;#8217;s Morning Edition, May 6, 2008. The story illustrates one of the many ways in which dispositionism is promoted (and, by implication, situationism is undermined). 

To listen to the story (roughly 4 minutes), click here. We have excerpted portions of the transcript below and added two videos (the first and second parts) of a remarkable Dan Rather interview of Ayn Rand.
* * *
 John Allison, CEO of banking giant BB&amp;T, calls Ayn Rand&amp;#8217;s novel Atlas Shrugged &amp;#8220;the best defense of capitalism ever written.&amp;#8221; He says that Rand changed his life, and he&amp;#8217;s working to ensure that the deceased author isn&amp;#8217;t left out of the nation&amp;#8217;s college curricula.
Since 2005, the BB&amp;amp...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1433968</comments>
            <pubDate>Sat, 10 May 2008 04:01:42 +0100</pubDate>
            <guid isPermaLink="false">1433968</guid>        </item>
        <item>
            <title>Conversation with Dan Gilbert</title>
            <link>http://www.medworm.com/index.php?rid=1405492&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2008%2F04%2F29%2Fconversation-with-dan-gilbert%2F</link>
            <description>Claudia Dreifus published her interview of Situationist friend, Dan Gilbert in The New York Times last week. It&amp;#8217;s a fascinating exchange. Here&amp;#8217;s a sample.
* * *
At Harvard, the social psychologist Daniel Gilbert is known as Professor Happiness. That is because the 50-year-old researcher directs a laboratory studying the nature of human happiness. Dr. Gilbert’s “Stumbling on Happiness” [see book cover in right margin] was a New York Times paperback best seller for 23 weeks and won the 2007 Royal Society Prize for Science Books.
Q. HOW DID YOU STUMBLE ONTO YOUR AREA OF STUDY?
A. It was something that happened to me roughly 13 years ago. I spent the first decade of my career studying what psychologists call “the fundamental attribution error,” which is about how people h...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1405492</comments>
            <pubDate>Tue, 29 Apr 2008 04:40:36 +0100</pubDate>
            <guid isPermaLink="false">1405492</guid>        </item>
        <item>
            <title>Health Central's CareConnection.com Features Variety of Experts</title>
            <link>http://www.medworm.com/index.php?rid=1403033&amp;cid=t_117220_158_f&amp;fid=36018&amp;url=http%3A%2F%2Fcaregiversbeacon.blogspot.com%2F2008%2F04%2Fhealth-centrals-careconnectioncom.html</link>
            <description>HealthCentral.com  provides a huge network of healthcare sites, including CareConnection.com for caregivers support, education, and resources.  Some of the experts featured include the following: (1) Suzanne Mintz, award-winning president and co-founder of the National Family Caregivers Association(2) Internationally known author, speaker, songwriter, and expert Cheryl Gartley. Cheryl is co-founder of &quot;Label Me Not&quot; and co-author of the anti-stigma song &quot;I Am More.&quot; She is the President and Founder of The Simon Foundation for Continence, and has been featured in magazines such as TIME, and Good Housekeeping.Cheryl writes posts at CareConnection.com that deal with living with conditions that have a stigma in society. (3) Internationally known speaker, attorney, author, and expert on aging, ...</description>
            <author>The Caregiver's Beacon - Resources, Links, Ideas, News</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1403033</comments>
            <pubDate>Sun, 27 Apr 2008 22:28:00 +0100</pubDate>
            <guid isPermaLink="false">1403033</guid>        </item>
        <item>
            <title>Dan Ariely interview is available on Books and Ideas #19</title>
            <link>http://www.medworm.com/index.php?rid=1401588&amp;cid=t_117220_122_f&amp;fid=36506&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBrainSciencePodcastBlog%2F%7E3%2F278304014%2F</link>
            <description>Discussion Forum (Source: the Brain Science Podcast and Blog with Dr. Ginger Campbell)</description>
            <author>the Brain Science Podcast and Blog with Dr. Ginger Campbell</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1401588</comments>
            <pubDate>Sat, 26 Apr 2008 14:52:13 +0100</pubDate>
            <guid isPermaLink="false">1401588</guid>        </item>
        <item>
            <title>Pharma Lobbies DC For Off-Label Rights</title>
            <link>http://www.medworm.com/index.php?rid=1382619&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F272818314%2F</link>
            <description>Drugmakers are descending on Washington to protect their freedom to advertise meds directly to consumers and push for looser government restrictions on off-label promotion, The Wall Street Journal writes.
Ten drugmakers, including Pfizer, Bayer Corp, AstraZeneca and Johnson &amp;#038; Johnson have formed a coalition to push for looser off-label restrictions and will submit their arguments today to the FDA, which has been soliciting comments on its proposed off-label promotion guidelines. They are represented by former FDA Chief Counsel Daniel Troy, who is working with public-relations giant APCO Worldwide. Patient-advocacy organizations such as the National Alliance on Mental Illness and the National Organization for Rare Disorders are also members.
The new coalition supports the ability of dr...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1382619</comments>
            <pubDate>Fri, 18 Apr 2008 11:12:09 +0100</pubDate>
            <guid isPermaLink="false">1382619</guid>        </item>
        <item>
            <title>Dan Rathers Reports on Neuroplasticity</title>
            <link>http://www.medworm.com/index.php?rid=1374042&amp;cid=t_117220_122_f&amp;fid=36506&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBrainSciencePodcastBlog%2F%7E3%2F270917874%2F</link>
            <description>Today HDNet™ is reshowing an episode of Dan Rather Reports called &amp;#8220;Mind Science.&amp;#8221; It is an excellent review of neuroplasticity. It includes interviews with several leading scientists in the field. I especially enjoyed seeing Nobel Laureate Eric Kandel talk about his work with memory. (I talked about Kandel&amp;#8217;s work on the Brain Science Podcast in Episode 3 and Episode 12.)
&amp;#8220;Mind Science&amp;#8221; also features the Dalai Llama and scientist Richard Davidson talking about the evidence that meditation can change the brain. Rather interviews Sharon Begely about her book Train Your Mind, Change Your Brain: How a New Science Reveals Our Extraordinary Potential to Transform Ourselves (which I discussed in detail in Episode 10 of the Brain Science Podcast). Other scientists fe...</description>
            <author>the Brain Science Podcast and Blog with Dr. Ginger Campbell</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1374042</comments>
            <pubDate>Tue, 15 Apr 2008 19:02:20 +0100</pubDate>
            <guid isPermaLink="false">1374042</guid>        </item>
        <item>
            <title>Physicians, Vaccines, and Autism</title>
            <link>http://www.medworm.com/index.php?rid=1358580&amp;cid=t_117220_133_f&amp;fid=35096&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAutismVox%2F%7E3%2F266802435%2F</link>
            <description>The medical professional in general and pediatricians in particular have sustained a certain amount of criticism in discussions about autism, and about the hypothetical vaccine-autism link in particular. Back in January, the American Academy of Pediatrics (AAP) sent a letter to the producers of the ABC legal drama, Eli Stone; the AAP was justifiably concerned about the TV show&amp;#8217;s presentation of the issue of vaccines and autism. Proponents of the theory that vaccines or something in vaccines causes autism issued some harsh criticism of the AAP (described by Respectful Insolence).
More recently, the AAP seems to be entering a stage of what might be détente with the proponents of a vaccine-autism link. It was recently reported that the AAP had met with some &amp;#8220;representatives&amp;#8221...</description>
            <author>Autism Vox</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1358580</comments>
            <pubDate>Wed, 09 Apr 2008 05:18:52 +0100</pubDate>
            <guid isPermaLink="false">1358580</guid>        </item>
        <item>
            <title>Why Novartis Eyed The Eye Business</title>
            <link>http://www.medworm.com/index.php?rid=1356372&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F266331522%2F</link>
            <description>As you may recall, Novartis yesterday agreed to pay $39 billion, in two stages, for Alcon, which markets various eye-care products. In a chat with The Wall Street Journal, ceo Dan Vasella explains the decision. This is an excerpt of an excerpt&amp;#8230;
WSJ: How does Alcon fit into your strategy?
Vasella: It fits perfectly well. From the point of view of portfolio management, we have said we want to strengthen the businesses which give us growth opportunities and balance risks. (Eye care) is a specialty area with high growth and diversification from the point of view of risk.
WSJ: What is attractive about eye care?
Vasella: Cataract surgery (and) lens implants (are) heavily age-related. Another factor is you have millions of people in countries like China, Russia, who need surgery and don&amp;#82...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1356372</comments>
            <pubDate>Tue, 08 Apr 2008 13:04:58 +0100</pubDate>
            <guid isPermaLink="false">1356372</guid>        </item>
        <item>
            <title>Excellent Recent Episodes of All in the Mind</title>
            <link>http://www.medworm.com/index.php?rid=1341216&amp;cid=t_117220_122_f&amp;fid=36506&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBrainSciencePodcastBlog%2F%7E3%2F261695396%2F</link>
            <description>Most of you know that I am a fan of the All in the Mind podcast from Australian radio. I want to recommend the two most recent episodes:
The March 22 Episode is actually  hosted by Volkart Wildermuth, from Germany. He interviews several of the world&amp;#8217;s leading primate researchers. You will learn some of the recent discoveries about primate intelligence and culture, and also hear an excellent discussion of what makes humans different. Go to the website not just to hear the show, but to get a transcript and to see the extensive links.
The March 29 Episode is a fascinating interview with Dan Ariely from MIT who is the author the new bestseller Predictably Irrational: The Hidden Forces That Shape Our Decisions, which describes his experiments in what is called behavioral economics. His w...</description>
            <author>the Brain Science Podcast and Blog with Dr. Ginger Campbell</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1341216</comments>
            <pubDate>Tue, 01 Apr 2008 03:27:16 +0100</pubDate>
            <guid isPermaLink="false">1341216</guid>        </item>
        <item>
            <title>Interpreting Facial Expressions</title>
            <link>http://www.medworm.com/index.php?rid=1315466&amp;cid=t_117220_109_f&amp;fid=36089&amp;url=http%3A%2F%2Fthesituationist.wordpress.com%2F2008%2F03%2F20%2Finterpreting-facial-expressions%2F</link>
            <description>Del Jones of USA Today has an interesting piece on the research of Dan Hill, an expert in facial coding, a system of classifying hundreds of tiny muscle movements in the face.  Below is a brief excerpt from the article as it pertains to the expressions of Senators Barrack Obama, Hillary Clinton, and John McCain.
 * * *
&amp;#8220;It is presidential season and Hill, president of Sensory Logic and author of a book about facial coding called Emotionomics: Winning Hearts and Minds, has been in demand to find clues in the faces of the candidates. John McCain forces smiles and, true to his reputation, angers easily, as demonstrated by puffed cheeks and a chin thrust upward in disgust, Hill says. Hillary Clinton smirks, an expression &amp;#8220;she oddly enough shares with President Bush,&amp;#8221; which co...</description>
            <author>The Situationist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1315466</comments>
            <pubDate>Thu, 20 Mar 2008 04:19:27 +0100</pubDate>
            <guid isPermaLink="false">1315466</guid>        </item>
        <item>
            <title>Brain Fitness Newsletter: Brain Awareness Week is March 10-16th</title>
            <link>http://www.medworm.com/index.php?rid=1270845&amp;cid=t_117220_122_f&amp;fid=36582&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FSharpBrains%2F%7E3%2F243943554%2F</link>
            <description>Here you are have the bi-monthly Digest of our 10 most Popular blog posts. (Also, remember that you can subscribe to receive our blog RSS feed, or to our newsletter at the top of this page if you want to receive this digest by email).


First, an announcement: March 10-16th is Brain Awareness Week, an international effort organized by the Dana Alliance for Brain Initiatives to advance public awareness about the progress and benefits of brain research. Join the hundreds of activities worldwide by visiting the International Calendar of events, or the week's main website.

Brain Fitness in the News
Cognitive Health and Training News: round-up of stimulating news, from Dakim raising over $10 million dollars to grow their retirement community offerings, to the full video of our 90-minute panel ...</description>
            <author>SharpBrains</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1270845</comments>
            <pubDate>Sat, 01 Mar 2008 17:17:16 +0100</pubDate>
            <guid isPermaLink="false">1270845</guid>        </item>
        <item>
            <title>Vasella To Shareholders: I’m A Cheap Date</title>
            <link>http://www.medworm.com/index.php?rid=1258593&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F241499423%2F</link>
            <description>Dan has found a new way to justify to shareholders his continued presence as both ceo and chairman of Novartis - he is saving them money. Speaking at the drugmaker&amp;#8217;s annual general meeting, he defended his dual role by saying that separating the two jobs would be inefficient and costly.
In companies where the jobs are held by different people, Dan argues that too much time and energy is spent settling conflicts, MarketWatch reports. As a result, costs rise - and not just because two people are being paid large sums. There &amp;#8220;is an even higher price to be paid, the price of inefficiency and conflict,&amp;#8221; he intones.
To back up his assertion, Dan cites a recent study by the Booz Allen consulting firm and contends that about 11 percent of ceo&amp;#8217;s leave their jobs due to confl...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1258593</comments>
            <pubDate>Tue, 26 Feb 2008 14:00:14 +0100</pubDate>
            <guid isPermaLink="false">1258593</guid>        </item>
        <item>
            <title>Brad Handley Offers Us A Chance To Evaluate</title>
            <link>http://www.medworm.com/index.php?rid=1212102&amp;cid=t_117220_133_f&amp;fid=35109&amp;url=http%3A%2F%2Fleftbrainrightbrain.co.uk%2F%3Fp%3D708</link>
            <description>A couple of days ago, Brad Handley wrote a blog entry on Age of Autism called &amp;#8216;DR. NANCY MINSHEW &amp;#38; ME: WHO&amp;#8217;S CRAZY?&amp;#8217;.

	The temptation to reply with a one word answer starting in &amp;#8216;y&amp;#8217; and ending in &amp;#8216;ou&amp;#8217; is nearly irresistible so I&amp;#8217;ll resist it. Let us instead examine Brad&amp;#8217;s criteria for deciding on who is crazy and who is not between Dr Minshew and he.

	I disagree with almost every single thing you have written or said about autism. Since we both can&amp;#8217;t possibly be right, one of us has to be crazy. I&amp;#8217;m scared to death it might be me. As a psychiatrist, I thought you could help.

	Says Brad to Dr Minshew in an email. He then continues with:

	It is maddening for parents like me that our &amp;#8220;experts&amp;#8221; can&amp;#8217;t ag...</description>
            <author>Left Brain/Right Brain</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1212102</comments>
            <pubDate>Wed, 06 Feb 2008 14:35:55 +0100</pubDate>
            <guid isPermaLink="false">1212102</guid>        </item>
        <item>
            <title>The Emerging Brain Fitness Software Market: Building Better Brains</title>
            <link>http://www.medworm.com/index.php?rid=1176355&amp;cid=t_117220_122_f&amp;fid=36582&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FSharpBrains%2F%7E3%2F222621494%2F</link>
            <description>Discussion 
Contact information and Registration Here.
Bios: 
Alvaro Fernandez, Co-founder, CEO SharpBrains.com. Alvaro is a leading voice and thought-leader in the growing science-based brain fitness market, Alvaro has been quoted by Los Angeles Times, Forbes, MSNBC, MarketWatch, among others, and is a guest blogger at the Huffington Post. Alvaro has presented trends in the emerging brain fitness market at multiple conferences and universities including the Neurotech Leaders Summit, Serious Games Summit, Stanford Business School, Neurotechnology Industry conference, the Institute for the Future, American Society on Aging (2007), and more. He started his career at McKinsey &amp;#038; Company and led the launch and turnaround of several publishing and education companies in the US and Europe,...</description>
            <author>SharpBrains</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1176355</comments>
            <pubDate>Fri, 25 Jan 2008 01:51:01 +0100</pubDate>
            <guid isPermaLink="false">1176355</guid>        </item>
        <item>
            <title>Welcome to the 17th Edition of Medicine 2.0 Blog Carnival!</title>
            <link>http://www.medworm.com/index.php?rid=1163224&amp;cid=t_117220_145_f&amp;fid=35710&amp;url=http%3A%2F%2Fksdescartin.wordpress.com%2F2008%2F01%2F20%2Fwelcome-to-the-17th-edition-of-medicine-20-blog-carnival%2F</link>
            <description>The Truth, Is It Still Out There?

Life, as we know it to be so far, always reserves space for seeking answers. The truth. And in our search for truth along the avenues and paths of explorations, lie many dimensions and perspectives. Other&amp;#8217;s truths may be some other&amp;#8217;s lies. While unfortunately, as knowledge unfolds, some opposing and constricting force, covers the light and distract those whose quest is simple&amp;#8211;to know the truth. 


Medicine, had its share in this unraveling and evolution. It too had its share of dark times. Though these days are definitely not dark times for understanding Medicine and Life, the current state is also neither the absolute truth. I have the opinion that we are in a spasmic process&amp;#8211;breaking down walls, tearing off false attachments fro...</description>
            <author>the story of healing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1163224</comments>
            <pubDate>Sun, 20 Jan 2008 17:18:18 +0100</pubDate>
            <guid isPermaLink="false">1163224</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Evening Round-Up</title>
            <link>http://www.medworm.com/index.php?rid=1159583&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F218520799%2F</link>
            <description>And so another busy day has come to an end. We hope you enjoyed it as much as we did. In fact, part of our time was spent devising interesting items for tomorrow. Meanwhile, we came across a few interesting tidbits to hope you while away the evening. Catch you later&amp;#8230;
For those interested in how a key opinion leader can help promote a drug, Health Care Renewal is a must read today. There is an instructive post about a campaign to market Johnson &amp;#038; Johnson&amp;#8217;s Risperdal for depression through &amp;#8220;commercially strategic clinical trials and journal publications that were really infomercials,&amp;#8221; the blog writes. To keep it simple, this involved the editor of a medical journal, who was also a KOL for J&amp;#038;J&amp;#8217;s Janssen while he co-authored a piece about Risperdal witho...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1159583</comments>
            <pubDate>Thu, 17 Jan 2008 23:48:57 +0100</pubDate>
            <guid isPermaLink="false">1159583</guid>        </item>
        <item>
            <title>Vasella: We May Not Sell Galvus In The US</title>
            <link>http://www.medworm.com/index.php?rid=1158445&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F218265011%2F</link>
            <description>The Novartis ceo is finally acknowledging that ongoing problems with its diabetes med may stop the drugmaker from refiling its application with the FDA. In remarks earlier today, Dan Vasella says Novartis hasn&amp;#8217;t yet completed discussions with the FDA about refiling requirements for Glavus, but it remains possible the drugmaker may not proceed with the filing at all, Dow Jones reports.
&amp;#8220;It&amp;#8217;s on the cards, that we won&amp;#8217;t refile, but it&amp;#8217;s also on the cards that we will,&amp;#8221; he says. &amp;#8220;But what is certainly clear, is that refiling without new data makes no sense.&amp;#8221; 
This comes after Novartis last fall found high doses of the diabetes pill are causing elevated liver enzyme levels, and that finding delayed the drug’s entry in Europe as a revision in pr...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1158445</comments>
            <pubDate>Thu, 17 Jan 2008 14:04:06 +0100</pubDate>
            <guid isPermaLink="false">1158445</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Weekend Send-Off</title>
            <link>http://www.medworm.com/index.php?rid=1131203&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F211364959%2F</link>
            <description>A quiet end to a short week. We apologize for the interruption in service, but we were attending a meeting that required a bit of travel. Now, however, we have returned to lasso a few items that have come to our attention in our absence. Meanwhile, we hope you enjoy the weekend. Our own to-do list includes shuttling about with one or more of the short people. See you shortly&amp;#8230;
As threatened, Lilly and its Japanese partner, Daiichi Sankyo, have asked the FDA to approve the prasugrel blood clot buster. The drugmakers submitted data from several clinical trials, including one that compared the drug to Plavix. The overall results demonstrated that for every 1,000 patients treated with prasugrel as compared with Plavix, there were 22 fewer patients with heart attacks, but, major bleeding o...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1131203</comments>
            <pubDate>Sat, 05 Jan 2008 01:59:16 +0100</pubDate>
            <guid isPermaLink="false">1131203</guid>        </item>
        <item>
            <title>Vasella: Novartis Cutbacks Are Looming</title>
            <link>http://www.medworm.com/index.php?rid=1085978&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F198585470%2F</link>
            <description>That&amp;#8217;s the word from ceo Dan Vasella, who tells The Wall Street Journal that the drugmaker is readying a companywide restructuring aimed at reducing &amp;#8220;layers of management and bureaucracy.&amp;#8221; This isn&amp;#8217;t new, though. He indicated as much two months ago (please look here).
Novartis plans to disclose more about the restructuring by mid-month and elaborate further in February, the paper writes, adding that the restructuring will involve some job cuts, but Vasella declined to say how many. In an October briefing for analysts, Novartis execs said there would be 240 jobs cut in US HQ functions, and 510 sales reps and 510 contracted reps positions eliminated, for savings of $230 million.
In his latest remarks, Vasella tells the paper that Novartis must become less bureaucratic...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1085978</comments>
            <pubDate>Tue, 11 Dec 2007 12:07:01 +0100</pubDate>
            <guid isPermaLink="false">1085978</guid>        </item>
        <item>
            <title>Holidays</title>
            <link>http://www.medworm.com/index.php?rid=1064310&amp;cid=t_117220_136_f&amp;fid=36162&amp;url=http%3A%2F%2Fwww.myelomablog.com%2F2007%2F12%2F01%2Fholidays%2F</link>
            <description>If you&amp;#8217;re in the mood to buy stuff, Hickory Farms has gifts under $25. Those petits fours were always my favorites when I was a kid, but it&amp;#8217;s been decades since I had one. Have you ever noticed that things that tasted good when we were children, lose their appeal when we grow up?&amp;#160; For [...] (Source: beth's myeloma blog)</description>
            <author>beth's myeloma blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1064310</comments>
            <pubDate>Sat, 01 Dec 2007 18:16:35 +0100</pubDate>
            <guid isPermaLink="false">1064310</guid>        </item>
        <item>
            <title>Independent Reviews For FDA Employee Misconduct</title>
            <link>http://www.medworm.com/index.php?rid=1060148&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F192523698%2F</link>
            <description>From now on, the Inspector General for the Department of Health and Human Services will have the pleasure of investigating wrongdoing by an FDA employee - and not share the responsibility with the FDA, a practice that has existed since 1998. Two months ago, the IG notified the FDA that it was withdrawing from the agreement, and all cases - such as theft or conflict of interest - are expected to be transferred by April, according to US Senator Chuck Grassley, who has spent much of the past few years digging into FDA practices.
&amp;#8220;No other agency within the Department has the kind of joint authority that the FDA had gotten for itself almost ten years ago,” Chuck says in a statement. “Cutting the tie is good for the public. It strengthens the role of the Inspector General. And in our ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1060148</comments>
            <pubDate>Thu, 29 Nov 2007 19:01:32 +0100</pubDate>
            <guid isPermaLink="false">1060148</guid>        </item>
        <item>
            <title>Guilty Pleasure: The Doctor As Drug Rep</title>
            <link>http://www.medworm.com/index.php?rid=1048566&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F189815483%2F</link>
            <description>In a first-person essay in The New York Times magazine, Danny Carlat, a psychiatrist and gadfly who publishes a newsletter about drug research and marketing, recounts how he was wooed by Wyeth to pitch Effexor to other docs. The tale is, basically, one man&amp;#8217;s primer on how the process often works - how the reps schmooze, the drugmaker pays and the doc is seduced. For those unfamiliar with the routine, this is worthy reading. For those in the know, this is a reminder of the ceaseless tension between marketing and science. This is how Carlat opens his mea culpa&amp;#8230;
&amp;#8220;On a blustery fall New England day in 2001, a friendly representative from Wyeth Pharmaceuticals came into my office in Newburyport, Mass., and made me an offer I found hard to refuse. He asked me if I’d like to g...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1048566</comments>
            <pubDate>Sat, 24 Nov 2007 22:36:40 +0100</pubDate>
            <guid isPermaLink="false">1048566</guid>        </item>
        <item>
            <title>FDA’s Woodcock: Blame Pharma For Approval Rate</title>
            <link>http://www.medworm.com/index.php?rid=1015909&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F182166702%2F</link>
            <description>Remember how more and more execs are carping about the agency? They blame the FDA for becoming too conservative in the wake of the Vioxx controversy and, as a result, fewer drugs are gaining approval.
For instance, this is from Fred Hassan, the Schering-Plough ceo: “It just indicates to you that when bureaucrats come under pressure, they tend to choose the path of asking for more data, as opposed to approving the drug.”
Wyeth&amp;#8217;s Bob Essner recently fumed: &amp;#8220;If you’re the first company to get approved in a certain area and competitors can’t get on the market, the FDA is now establishing monopolies. And that’s certainly not their mandate.” 
And this is what Dan Vasella at Novartis had to say: “The discussion on what this drug brings over and above what’s on the mark...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1015909</comments>
            <pubDate>Fri, 09 Nov 2007 12:48:30 +0100</pubDate>
            <guid isPermaLink="false">1015909</guid>        </item>
        <item>
            <title>Wyeth’s Essner Takes Parting Shot At FDA</title>
            <link>http://www.medworm.com/index.php?rid=1003705&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F180045114%2F</link>
            <description>As Bob prepares to leave the ceo job on Jan. 1 and become chairman for an unspecified period of time, he&amp;#8217;s using his final weeks to sound off quite sharply about the FDA, which has caused Wyeth unending aggravation this year by refusing to approve some of its drugs.
In an interview with The Financial Times, Bob say the FDA &amp;#8220;is establishing monopolies&amp;#8221; by denying drug approvals. He&amp;#8217;s concerned that FDA assessments now include whether a drug can work better than an existing product, instead of allowing the market to determine what it wants. Specifically, he says the FDA was blocking new drugs after their efficacy was compared to those already on the market. This is, he claims, beyond the FDA&amp;#8217;s mandate and could prompt legal action. Whether he is about to sue isn...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1003705</comments>
            <pubDate>Mon, 05 Nov 2007 13:42:24 +0100</pubDate>
            <guid isPermaLink="false">1003705</guid>        </item>
        <item>
            <title>Jenny McCarthy: responding to criticism</title>
            <link>http://www.medworm.com/index.php?rid=979212&amp;cid=t_117220_133_f&amp;fid=35081&amp;url=http%3A%2F%2Fmikestanton.wordpress.com%2F2007%2F10%2F25%2Fjenny-mccarthy-responding-to-criticism%2F</link>
            <description>First, an apology.
My offline existence has led me to neglect Action For Autism recently. This at a time when my blog has never been more popular. But I have no illusions about the reason. It is all down to Jenny McCarthy. I wrote a couple of short pieces about her and Google did the rest. As a [...] (Source: Action For Autism)</description>
            <author>Action For Autism</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=979212</comments>
            <pubDate>Thu, 25 Oct 2007 23:55:16 +0100</pubDate>
            <guid isPermaLink="false">979212</guid>        </item>
        <item>
            <title>FDA’s New Chief Counsel Is A Familiar Name</title>
            <link>http://www.medworm.com/index.php?rid=956252&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F170782382%2F</link>
            <description>Gerald Masoudi is back. After spending the last two years as deputy assistant attorney general in charge of international, policy and appellate matters in the antitrust division of the Department of Justice, he replaces Sheldon Bradshaw, who left last month, as the chief FDA lawyer. Masoudi previously held this role - but only on acting basis - after Dan Troy resigned in November 2004. He was hired just before the controversial Troy resigned.
“We are pleased to have Jerry’s expertise and insight back at HHS,” says FDA commish Andy von Eschenbach, in a brief statement. “His leadership and service will be critical to FDA’s public health mission and regulatory responsibilities.”
Masoudi, who graduated from the University of Chicago Law School in 1993, where he was the editor of th...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=956252</comments>
            <pubDate>Tue, 16 Oct 2007 19:24:43 +0100</pubDate>
            <guid isPermaLink="false">956252</guid>        </item>
        <item>
            <title>Wyeth’s Ruffolo: India Looks Good To Us</title>
            <link>http://www.medworm.com/index.php?rid=932723&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F166147909%2F</link>
            <description>Dan Vasella may be smarting that India won&amp;#8217;t extend a wider patent for his Gleevec cancer med, but Wyeth&amp;#8217;s R&amp;#038;D chief isn&amp;#8217;t worried such moves bode ill for big pharma. After inaugurating a new $10 million, R&amp;#038;D facility in Hyderabad, Bob Ruffolo told The Business Standard that its&amp;#8217; time to think beyond maintaining only research operations in India.
He&amp;#8217;s looking at making drugs in India, too. &amp;#8220;We are starting to look at manufacturing operations in India for both APIs and new drugs,&amp;#8221; he says. And so while the Novartis ceo sulks in Switzerland and vows to switch hundreds of millions of dollars in investments to China, rivals are looking at moving into that other big market Dan wants to forsake. Maybe Vasella&amp;#8217;s retaliatory decision should...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=932723</comments>
            <pubDate>Sat, 06 Oct 2007 12:56:59 +0100</pubDate>
            <guid isPermaLink="false">932723</guid>        </item>
        <item>
            <title>Autism Parents and Celebrity Endorsements</title>
            <link>http://www.medworm.com/index.php?rid=915374&amp;cid=t_117220_133_f&amp;fid=35081&amp;url=http%3A%2F%2Fmikestanton.wordpress.com%2F2007%2F09%2F30%2Fautism-parents-and-celebrity-endorsements%2F</link>
            <description>Now that the Jenny McCarthy bandwagon appears to be slowing down it is as well to remember that lots of parents are writing intelligent, heart warming and thought provoking accounts of their experience in raising a child with autism. Lacking McCarthy&amp;#8217;s dubious claims to fame and fortune, not many of them get the chance to publish a book or [...] (Source: Action For Autism)</description>
            <author>Action For Autism</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=915374</comments>
            <pubDate>Sun, 30 Sep 2007 22:57:58 +0100</pubDate>
            <guid isPermaLink="false">915374</guid>        </item>
        <item>
            <title>On The Couch… Weekend Reading</title>
            <link>http://www.medworm.com/index.php?rid=915414&amp;cid=t_117220_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F163271037%2F</link>
            <description>Finished the chores? Curling up with a cup of coffee? Trying to relax? Then the time has come to catch up on events. Here are a few items to enjoy before you head off to pick some apples or talk a walk in the park&amp;#8230;
Drugmakers often complain their good deeds go unnoticed, or worse. So Time magazine has run a piece about Merck&amp;#8217;s efforts to provide HIV meds in Botswana. The drugmaker wins praise from its partner, the government and Gates Foundation, although the mag doesn&amp;#8217;t bother to ask one of the NGOs, or non-governmental organizations, for a quick comment.
Novartis ceo Dan Vasella, who has felt the sting of rejected drugs more than once lately, complains that the FDA has become politicized. &amp;#8220;The FDA has become subject to politics. If they are assailed like they are ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=915414</comments>
            <pubDate>Sun, 30 Sep 2007 17:02:19 +0100</pubDate>
            <guid isPermaLink="false">915414</guid>        </item>
    </channel>
</rss>

